Update June 01- June 07, 2020, Dr. Peter J. Lansberg MD, PhD

Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics

COVID-19 publications - Week 23 2020 899 Publications

PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected]

Reliable on-line resources for Covid 19

WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker AAN - Neurology resources COVID-19 resources (Harvard) COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF)

COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins)

Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance

Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database

Mainstream Media Billionaire scientist’s COVID-19 vaccine selected for monkey tests(Science) How Iceland Beat the Coronavirus (New Yorker) Iran's rapid rise in Covid-19 cases stokes fears of the second wave (Guardian) Malaria Drug Did Not Prevent COVID Infections, Study Finds (NYT) Man Behind Sweden’s Controversial Virus Strategy Admits Mistakes (Bloomberg) Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ (Science) Surgisphere: governments suspect data from tiny US company (Guardian) Genes May Leave Some People More Vulnerable to Severe Covid-19 (NYT) The pandemic's first major research scandal erupts (Science) The Lancet has made one of the biggest retractions in modern history (Guardian) Half of Coronavirus Spread May Traced to People Without Any Symptoms (TIMES) Coronavirus crowds out other research papers (Nature index) Important Mysteries About Coronavirus Endure (NYT) The search for a COVID-19 vaccine is gaining momentum (S. Diego Union Tribune)

KeyArticles

1. COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 2020; Teuwen LA, Geldhof V, Pasut A, Carmeliet P. http://www.ncbi.nlm.nih.gov/pubmed/? term=32439870

2. Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV- 2? Am J Physiol Endocrinol Metab 2020; Cao X, Yin R, Albrecht H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501731

3. The role of high cholesterol in age-related COVID19 lethality. bioRxiv preprint doi: https://doi.org/10.1101/2020.05.09.086249; Hao Wang, Zixuan Yuan, Mahmud Arif Pavel, Scott B. Hansen

4. Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS- CoV-2) Infection. J Med Virol 2020; Zhuang MW, Cheng Y, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497323

5. The immune system and COVID-19: Friend or foe? Life Sci 2020:117900Yazdanpanah F, Hamblin MR, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502542

6. Endothelial cell infection and endotheliitis in COVID-19. The Lancet 2020; 395:1417-1418Varga Z, Flammer AJ, Steiger P et al.

7. Diagnostic performance of 7 rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clin Microbiol Infect 2020; Van Elslande J, Houben E, Depypere M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473953

8. Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circ Heart Fail 2020; Ranard LS, Fried JA, Abdalla M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500721

9. Biomarkers associated with COVID-19 disease progression. Crit. Rev. Clin. Lab. Sci. 2020:1-11Ponti G, Maccaferri M, Ruini C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503382

10. Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ). Heart Lung Circ. 2020; Nicholls SJ, Nelson M, Astley C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473781|

11. COVID-19 Related Coagulopathy: A Distinct Entity? J Clin Med 2020; 9Marchandot B, Sattler L, Jesel L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32486469

12. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA). Vasa 2020:1-5Linnemann B, Bauersachs R, Grebe M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501145

13. Renin-Angiotensin-System (RAS) and COVID-19 - On the Prescription of RAS Blockers. Deutsche Medizinische Wochenschrift 2020; 145:682- 686Kreutz R, Abd El-Hady Algharably E, Ganten D, Messerli F.

14. Association of hypertension and antihypertensive treatment with COVID- 19 mortality: a retrospective observational study. Eur Heart J 2020; Gao C, Cai Y, Zhang K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498076

15. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369:m1985Docherty AB, Harrison EM, Green CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32444460

Basic Science (27 articles)

1. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY) 2020; 12Asselta R, Paraboschi EM, Mantovani A, Duga S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501810 2. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020; Radzikowska U, Ding M, Tan G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496587 3. Related molecular mechanisms of COVID-19, hypertension, and diabetes. Am J Physiol Endocrinol Metab 2020; 318:E881Akkus E, Sahin M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479159 4. S1 Subunit and Host Proteases as Potential Therapeutic Avenues for the Treatment of COVID-19. Arch Med Res 2020; Arafah A, Ali S, Yatoo AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493626 5. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2. Arch Med Res 2020; Satarker S, Nampoothiri M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493627 6. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections. Biomed. Pharmacother. 2020; 128:110296Ghafouri-Fard S, Noroozi R, Vafaee R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480226 7. Interaction of the prototypical alpha-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex. Comput. Biol. Chem. 2020; 87:107292Liang J, Pitsillou E, Karagiannis C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485652 8. COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice. Hum Genomics 2020; 14:20Lutz C, Maher L, Lee C, Kang W. http://www.ncbi.nlm.nih.gov/pubmed/? term=32498696 9. Human Gene Sequences in SARS-CoV-2 and Other Viruses. In Vivo 2020; 34:1633-1636Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503822 10. SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1. In Vivo 2020; 34:1629-1632Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503821 11. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation. Infect Genet Evol 2020:104386Dinka H, Milkesa A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473977 12. Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach. Infect Genet Evol 2020:104389Lokman SM, Rasheduzzaman MD, Salauddin A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502733 13. SARS-CoV-2 molecular and phylogenetic analysis in COVID-19 patients: A preliminary report from Iran. Infect Genet Evol 2020:104387Tabibzadeh A, Zamani F, Laali A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485332 14. A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2. Int. J. Biol. Macromol. 2020; Wang M, Fu T, Hao J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485251 15. Antiviral Effects of Probiotic metabolites on COVID-19. J Biomol Struct Dyn 2020:1-11Anwar F, Altayb HN, Al-Abbasi FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475223 16. Virtual Screening-Driven Drug Discovery of SARS-CoV2 Enzyme Inhibitors Targeting Viral Attachment, Replication, Post-Translational Modification and Host Immunity Evasion Infection Mechanisms. J Biomol Struct Dyn 2020:1-23Quimque MTJ, Notarte KIR, Fernandez RAT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476574 17. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission. J Med Virol 2020; Benvenuto D, Demir AB, Giovanetti M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32492183 18. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing. J Med Virol 2020; Chan WM, Ip JD, Chu AW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501535 19. Letter to the Editor: A Missing Link between SARS-CoV-2 and the Eye?: ACE2 Expression on the Ocular Surface. J Med Virol 2020; Grajewski RS, Rokohl AC, Becker M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497334 20. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer. J Med Virol 2020; Sagkan RI, Akin-Bali DF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492203 21. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti- infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2. J. Recept. Signal Transduct. Res. 2020:1-8Maurya SK, Maurya AK, Mishra N, Siddique HR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476594 22. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications. Life Sci 2020:117905Banu N, Panikar SS, Leal LR, Leal AR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504757 23. What would Sergio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system? Med. Hypotheses 2020; 143:109886Nicolau LAD, Magalhaes PJC, Vale ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504925 24. Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses. Nanomaterials (Basel) 2020; 10Nasrollahzadeh M, Sajjadi M, Soufi GJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486364 25. The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. North Clin Istanb 2020; 7:203-209Karacan I, Akgun TK, Agaoglu NB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478289 26. Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19. SLAS Discov 2020:2472555220934421Scalise M, Indiveri C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500793 27. [Application of Reyanning Mixture in evaluating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome]. Zhongguo Zhong Yao Za Zhi 2020; 45:1465-1472Bao L, Shi YJ, Geng ZH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489022

Biomarkers - Genetics (83 articles)

1. Diagnostic Performance of a Rapid Point of Care Test for SARS-CoV-2 in an Urban ED Setting. Acad Emerg Med 2020; McDonald S, Courtney DM, Clark AE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32492760 2. Drive-Through COVID-19 Testing During the 2020 Pandemic: a safe, efficient, and scalable model for pediatric patients and healthcare workers. Acad. Pediatr. 2020; Flynn EF, Kuhn E, Shaik M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479895 3. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY) 2020; 12Asselta R, Paraboschi EM, Mantovani A, Duga S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501810 4. Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients. Aging (Albany NY) 2020; 12Yang AP, Li HM, Tao WQ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484453 5. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020; Radzikowska U, Ding M, Tan G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496587 6. Nasopharyngeal swab collection in the suspicion of Covid-19. Am. J. Otolaryngol. 2020:102551Piras A, Rizzo D, Longoni E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487335 7. Expedited SARS-CoV-2 Screening of Donors and Recipients Supports Continued Solid Organ Transplant. Am J Transplant 2020; Lieberman JA, Mays JA, Wells C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476285 8. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann. Hematol. 2020; Liu X, Zhang R, He G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495027 9. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Biomark. Med. 2020; Li J, Li M, Zheng S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490680 10. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections. Biomed. Pharmacother. 2020; 128:110296Ghafouri-Fard S, Noroozi R, Vafaee R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480226 11. Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study. BMC Med 2020; 18:168Shi J, Li Y, Zhou X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493370 12. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell 2020; Shen B, Yi X, Sun Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492406 13. Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies. Clin Chem 2020; Favresse J, Eucher C, Elsen M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484887 14. In Reply: COVID-19: An Argument for Rapid Access to Laboratory Data Warehouses. Clin Chem 2020; Jackups R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474583 15. Clinical Performance of the Roche SARS-CoV-2 Serologic Assay. Clin Chem 2020; Tang MS, Hock KG, Logsdon NM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484860 16. Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19). Clin Chem Lab Med 2020; Bonetti G, Manelli F, Bettinardi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484450 17. Comparison of the Elecsys(R) Anti-SARS-CoV-2 immunoassay with the EDI(TM) enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma. Clin Chim Acta 2020; Egger M, Bundschuh C, Wiesinger K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485155 18. ELEVATED MONOCYTE DISTRIBUTION WIDTH IN COVID-19 PATIENTS: THE CONTRIBUTION OF THE NOVEL SEPSIS INDICATOR. Clin Chim Acta 2020; Ognibene A, Lorubbio M, Magliocca P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504637 19. Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? Clin Chim Acta 2020; Plebani M, Padoan A, Negrini D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32485157 20. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza. Clin Infect Dis 2020; Gu S, Chen Y, Wu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497191 21. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients. Clin Infect Dis 2020; Wang X, Guo X, Xin Q et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497196 22. SARS-CoV-2 serology: Test, test, test, but interpret with caution! Clin Med (Lond) 2020; Bermingham WH, Wilding T, Beck S, Huissoon A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487681 23. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected COVID-19 presenting to the hospital. Clin Microbiol Infect 2020; Ong DSY, de Man SJ, Lindeboom FA, Koeleman JGM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502646 24. Diagnostic performance of 7 rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clin Microbiol Infect 2020; Van Elslande J, Houben E, Depypere M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473953 25. Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients. Crit Care 2020; 24:290Wu Z, Hu R, Zhang C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503680 26. Biomarkers associated with COVID-19 disease progression. Crit. Rev. Clin. Lab. Sci. 2020:1-11Ponti G, Maccaferri M, Ruini C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503382 27. What Do We Need to Know to Improve Diagnostic Testing Methods for the 2019 Novel Coronavirus? Cureus 2020; 12:e8263Mustafa Z, Ghaffari M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483515 28. Novel wastewater surveillance strategy for early detection of coronavirus disease 2019 hotspots. Curr Opin Environ Sci Health 2020; 17:8-13Venugopal A, Ganesan H, Sudalaimuthu Raja SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501429 29. Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens. Curr Protoc Cytom 2020; 93:e77Bain W, Lee JS, Watson AM, Stitt-Fischer MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502333 30. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents. Cytometry A 2020; Reifel KM, Swan BK, Jellison ER et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488957 31. Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings. Diabetes Metab Syndr 2020; 14:753-756Goyal A, Gupta S, Gupta Y, Tandon N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502958 32. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul. Emerg Infect Dis 2020; 26Han MS, Seong MW, Kim N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497001 33. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 2020; 9:1123-1130Han H, Ma Q, Li C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475230 34. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression. Emerg Microbes Infect 2020; 9:1096-1101Shen L, Wang C, Zhao J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476607 35. Keys for analysis of diagnostic and serologic tests for CoV-2. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2020; Laccourreye O, Cohen R, Couloigner V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473864 36. Authors' response: SARS-CoV-2 detection by real-time RT-PCR. Euro Surveill 2020; 25Corman VM, Drosten C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489177 37. Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR. Euro Surveill 2020; 25Pillonel T, Scherz V, Jaton K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489175 38. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil. Steril. 2020; 113:1135-1139Pan F, Xiao X, Guo J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482249 39. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide. Hla 2020; Barquera R, Collen E, Di D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475052 40. NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19. Immunol. Invest. 2020:1-9Kerboua KE. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482134 41. Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications. In Vivo 2020; 34:1589-1592Smetana K, Jr., Brabek J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503815 42. SARS-CoV-2 Laboratory Testing in India's Pandemic Response: A Public Health Perspective. Indian J. Public Health 2020; 64:S128-s131Moorthy M, Fletcher J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496242 43. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation. Infect Genet Evol 2020:104386Dinka H, Milkesa A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473977 44. SARS-CoV-2 molecular and phylogenetic analysis in COVID-19 patients: A preliminary report from Iran. Infect Genet Evol 2020:104387Tabibzadeh A, Zamani F, Laali A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485332 45. Universal screening for SARS-CoV-2 in asymptomatic obstetric patients in Tokyo, Japan. Int J Gynaecol Obstet 2020; Ochiai D, Kasuga Y, Iida M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496574 46. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples. Int J Infect Dis 2020; Alcoba-Florez J, Gonzalez-Montelongo R, Inigo-Campos A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492531 47. Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Int J Infect Dis 2020; Porte L, Legarraga P, Vollrath V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497809 48. SARS-CoV-2 Antibody Testing - Questions to be asked. J Allergy Clin Immunol 2020; Ozcurumez MK, Ambrosch A, Frey O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479758 49. Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene. J Appl Lab Med 2020; SoRelle JA, Frame I, Falcon A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483586 50. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay. J. Clin. Lab. Anal. 2020:e23391Gu X, Li X, An X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488888 51. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study. J. Clin. Lab. Anal. 2020:e23415Shi M, Chen L, Yang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488958 52. A Comprehensive Approach Is Vital for Diagnosing COVID-19: A Case of False Negative. J. Clin. Med. Res. 2020; 12:315-319Balla M, Merugu GP, Pokal M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489507 53. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies. J Clin Virol 2020; 129:104468Beavis KG, Matushek SM, Abeleda APF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485620 54. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital. J Clin Virol 2020; 129:104472Blairon L, Wilmet A, Beukinga I, Tre-Hardy M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504944 55. Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity. J Clin Virol 2020; 128:104469Bosworth A, Whalley C, Poxon C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474371 56. Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance. J Clin Virol 2020; 129:104474Degli-Angeli E, Dragavon J, Huang ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504946 57. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study. J Clin Virol 2020; 129:104473Perez-Garcia F, Perez-Tanoira R, Romanyk J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504945 58. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol 2020; 129:104455Scohy A, Anantharajah A, Bodeus M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32485618 59. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients. J Infect 2020; Tuaillon E, Bollore K, Pisoni A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504735 60. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study. J Infect Dis 2020; Hao S, Lian J, Lu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474608 61. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care 2020; 8:36Huang I, Pranata R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483488 62. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis. J Med Virol 2020; Aikawa T, Takagi H, Ishikawa K, Kuno T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484975 63. Potential pitfalls of routine SARS-CoV-2 serology for mass screening. J Med Virol 2020; Belec L, Pere H, Bouassa RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484942 64. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission. J Med Virol 2020; Benvenuto D, Demir AB, Giovanetti M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32492183 65. Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients. J Med Virol 2020; Carmo A, Pereira-Vaz J, Mota V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484958 66. COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature. J Med Virol 2020; Murt A, Eskazan AE, Yilmaz U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497344 67. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer. J Med Virol 2020; Sagkan RI, Akin-Bali DF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492203 68. A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19. J Med Virol 2020; Zhang Z, Wang S, Tu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501538 69. Bonuses and pitfalls of a paperless drive-through screening and COVID-19: A field report. J Microbiol Immunol Infect 2020; Lee E, Mohd Esa NY, Wee TM, Soo CI. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474025 70. Au-decorated BN nanotube as a breathalyzer for potential medical applications. J. Mol. Liq. 2020; 312:113454Ge C, Li M, Li M, Peyghan AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501315 71. The different tests for the diagnosis of COVID-19 - A review in Brazil so far. JBRA Assist Reprod 2020; Laureano AFS, Riboldi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32491306 72. Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease. JCI Insight 2020; Zhao Y, Qin L, Zhang P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501293 73. The potential transmission of SARS-CoV-2 from patients with negative RT-PCR swab tests to others: two related clusters of COVID-19 outbreak. Jpn. J. Infect. Dis. 2020; Cao G, Tang S, Yang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475877 74. A Case of COVID-19 Patient with False-negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese traveller Returning from Wuhan, Hubei Province, China, January 2020. Jpn. J. Infect. Dis. 2020; Ishikane M, Miyazato Y, Kustuna S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475881 75. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications. Life Sci 2020:117905Banu N, Panikar SS, Leal LR, Leal AR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504757 76. The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19. New Microbes New Infect 2020; 36:100697Khan FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483490 77. The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. North Clin Istanb 2020; 7:203-209Karacan I, Akgun TK, Agaoglu NB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478289 78. Differentiating Between 2019 Novel Coronavirus Pneumonia and Influenza Using a Nonspecific Laboratory Marker-Based Dynamic Nomogram. Open Forum Infect Dis 2020; 7:ofaa169Wang L, Liu Y, Zhang T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490031 79. Oral saliva and CVID-19. Oral Oncol 2020; 108:104821Baghizadeh Fini M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474389 80. Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays. Protein Expr. Purif. 2020:105686Esposito D, Mehalko J, Drew M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32504802 81. Characteristics and assessment of the usefulness of serological tests in the diagnostic of infections caused by coronavirus SARS-CoV-2 on the basis of available manufacturer's data and literature review. Przegl. Epidemiol. 2020; 74:49-68Rastawicki W, Rokosz-Chudziak N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500987 82. Utility of lateral flow tests in SARS-CoV-2 infection monitorization. Rev. Esp. Quimioter. 2020; Candel FJ, Vinuela-Prieto JM, Gonzalez Del Castillo J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492991 83. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:488Li J, Zhang C, Wu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503657 84. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci 2020; Goker H, Aladag Karakulak E, Demiroglu H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496734

Children (25 articles)

1. Understanding the age divide in COVID-19: Why are children overwhelmingly spared? Am J Physiol Lung Cell Mol Physiol 2020; Lingappan K, Karmouty-Quintana H, Davies J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32491949 2. The role of pulmonary CT scans for children during the COVID-19 pandemic. BMC Med 2020; 18:171Sinha IP, Kaleem M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498685 3. COVID-19, economic impact and child mortality: A global concern. Clin. Nutr. 2020; Kabir M, Saqib MAN, Zaid M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499056 4. Global Coronavirus Pandemic (SARS CoV-2): Past, Present, And Future Of Pediatric Dermatology. Dermatol Ther 2020:e13767Simonetti O, Diotallevi F, Campanati A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500648 5. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl. Dermatol Ther 2020:e13770Yozgat CY, Uzuner S, Duramaz BB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500647 6. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul. Emerg Infect Dis 2020; 26Han MS, Seong MW, Kim N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497001 7. Point-of-care lung ultrasound in three neonates with COVID-19. Eur. J. Pediatr. 2020; Gregorio- Hernandez R, Escobar-Izquierdo AB, Cobas-Pazos J, Martinez-Gimeno A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504135 8. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks. Eur. J. Pediatr. 2020; Parri N, Magista AM, Marchetti F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495147 9. Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur. J. Pediatr. 2020; Sanna G, Serrau G, Bassareo PP et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474800 10. No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020. Euro Surveill 2020; 25Heavey L, Casey G, Kelly C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489179 11. Asymptomatic COVID-19 infection in a child with nasal foreign body. Int J Pediatr Otorhinolaryngol 2020; 135:110092Diercks GR, Park BJ, Myers LB, Kwolek CJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=32480136 12. Adolescents' Motivations to Engage in Social Distancing During the COVID-19 Pandemic: Associations With Mental and Social Health. J. Adolesc. Health 2020; Oosterhoff B, Palmer CA, Wilson J, Shook N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487491 13. The Unexpected Risks of COVID-19 on Asthma Control in Children. J Allergy Clin Immunol Pract 2020; Oreskovic NM, Kinane TB, Aryee E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497662 14. Rapid Systematic Review: The Impact of Social Isolation and Loneliness on the Mental Health of Children and Adolescents in the Context of COVID-19. J. Am. Acad. Child Adolesc. Psychiatry 2020; Loades ME, Chatburn E, Higson-Sweeney N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504808 15. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro- inflammatory and anti-inflammatory cytokines. J Biol Regul Homeost Agents 2020; 34Ronconi G, Tete G, Kritas SK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476380 16. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study. J. Clin. Lab. Anal. 2020:e23415Shi M, Chen L, Yang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488958 17. Characteristics of Hospitalized Pediatric COVID-19 Cases - Chicago, Illinois, March - April 2020. J Pediatric Infect Dis Soc 2020; Mannheim J, Gretsch S, Layden JE, Fricchione MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479632 18. The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co- infection with other respiratory viruses. Jpn. J. Infect. Dis. 2020; Kakuya F, Okubo H, Fujiyasu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475878 19. Neonates Hospitalized with Community-Acquired SARS-CoV-2 in a Colorado Neonatal Intensive Care Unit. Neonatology 2020:1-5White A, Mukherjee P, Stremming J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498065 20. Pediatric coronavirus disease 2019 (COVID-19): An insight from west of Iran. North Clin Istanb 2020; 7:284-291Soltani J, Sedighi I, Shalchi Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478302 21. Clinical Manifestations of Children with COVID-19: a Systematic Review. Pediatr Pulmonol 2020; de Souza TH, Nadal JA, Nogueira RJN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492251 22. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS. Pediatr Pulmonol 2020; Hon KL, Leung KKY, Leung AKC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483934 23. Paediatric aspects of COVID-19: An update. Respir Med Res 2020; 78:100765Kammoun R, Masmoudi K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504982 24. Analysis and suggestions for the preview and triage screening of children with suspected COVID-19 outside the epidemic area of Hubei Province. Transl Pediatr 2020; 9:126-132Zhang N, Deng Y, Li W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32477912 25. SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China. World J Pediatr 2020; Sun D, Chen X, Li H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504360

Clinical Features (39 articles)

1. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369:m1985Docherty AB, Harrison EM, Green CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32444460 2. Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis. Clin Res Hepatol Gastroenterol 2020; Zhai LL, Xiang F, Wang W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482542 3. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis. Dermatol Ther 2020:e13768Demirbas A, Elmas OF, Tursen U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500589 4. Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab. Dermatol Ther 2020; Valenti M, Facheris P, Pavia G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474988 5. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl. Dermatol Ther 2020:e13770Yozgat CY, Uzuner S, Duramaz BB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500647 6. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19). Diagnosis (Berl) 2020; Lippi G, Mattiuzzi C, Bovo C, Henry BM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478675 7. Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020. Emerg Infect Dis 2020; 26Lechien JR, Chetrit A, Chekkoury-Idrissi Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32491984 8. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks. Eur. J. Pediatr. 2020; Parri N, Magista AM, Marchetti F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495147 9. Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur. Urol. 2020; Mumm JN, Osterman A, Ruzicka M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475747 10. Ocular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol 2020; Bostanci Ceran B, Ozates S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504100 11. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature. In Vivo 2020; 34:1619-1628Douglas KAA, Douglas VP, Moschos MM. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503820 12. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res 2020; Criado PR, Abdalla BMZ, de Assis IC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488318 13. Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19. Int J Infect Dis 2020; Li P, Chen L, Liu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492533 14. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study. Intern Emerg Med 2020; Lapostolle F, Schneider E, Vianu I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474850 15. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol 2020; Freeman EE, McMahon DE, Lipoff JB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479979 16. CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC ("COVID TOES"): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES. J Am Acad Dermatol 2020; Kanitakis J, Lesort C, Danset M, Jullien D. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502585 17. Reply to: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak". J Am Acad Dermatol 2020; Ruggiero G, Arcangeli F, Lotti T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497698 18. High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients. J Am Coll Cardiol 2020; Voicu S, Bonnin P, Stepanian A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479784 19. Burnout and Posttraumatic Stress Disorder in the Coronavirus Disease 2019 (COVID-19) Pandemic: Intersection, Impact, and Interventions. J Am Coll Radiol 2020; Restauri N, Sheridan AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479798 20. Characteristics of U.S. Nursing Homes with COVID-19 Cases. J Am Geriatr Soc 2020; Abrams HR, Loomer L, Gandhi A, Grabowski DC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484912 21. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study. J Clin Virol 2020; 129:104475Yang L, Liu J, Zhang R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485619 22. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J. Endocrinol. Invest. 2020; Ippolito S, Dentali F, Tanda ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488726 23. Retiform purpura as a dermatological sign of covid-19 coagulopathy. J Eur Acad Dermatol Venereol 2020; Bosch-Amate X, Giavedoni P, Podlipnik S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32491234 24. Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report. J Eur Acad Dermatol Venereol 2020; Hashizume H, Sano Y, Furukawa S, Imokawa S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495957 25. No antibody response in acral cutaneous manifestations associated with COVID-19 ? J Eur Acad Dermatol Venereol 2020; Mahieu R, Tillard L, Le Guillou-Guillemette H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488946 26. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients. J Eur Acad Dermatol Venereol 2020; Reymundo A, Fernaldez-Bernaldez A, Reolid A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495368 27. Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas? J Eur Acad Dermatol Venereol 2020; Rosell-Diaz AM, Mateos-Mayo A, Nieto-Benito LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495400 28. SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes. J Infect 2020; Graham N, Junghans C, Downes R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32504743 29. Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients. J Med Virol 2020; Carmo A, Pereira-Vaz J, Mota V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484958 30. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD- 19 patient with diarrhea. J Med Virol 2020; Carnevale S, Beretta P, Morbini P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492199 31. Letter to the Editor: A Missing Link between SARS-CoV-2 and the Eye?: ACE2 Expression on the Ocular Surface. J Med Virol 2020; Grajewski RS, Rokohl AC, Becker M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497334 32. COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature. J Med Virol 2020; Murt A, Eskazan AE, Yilmaz U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497344 33. Coronavirus Disease 2019 Presenting as Conjunctivitis. Korean J Fam Med 2020; Ying NY, Idris NS, Muhamad R, Ahmad I. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475104 34. Predicting COVID-19 Incidence Using Anosmia and Other COVID-19 Symptomatology: Preliminary Analysis Using Google and Twitter. Otolaryngol Head Neck Surg 2020:194599820932128Panuganti BA, Jafari A, MacDonald B, DeConde AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484425 35. Clinical Manifestations of Children with COVID-19: a Systematic Review. Pediatr Pulmonol 2020; de Souza TH, Nadal JA, Nogueira RJN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492251 36. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev Med Virol 2020:e2112Pormohammad A, Ghorbani S, Khatami A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502331 37. Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China. Theranostics 2020; 10:6113-6121Li L, Yang L, Gui S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483442 38. Descriptive characteristics of hospitalized adult smokers and never-smokers with COVID-19. Tob Induc Dis 2020; 18:46Kalan ME, Ghobadi H, Taleb ZB et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489343 39. Characteristics of the initial patients hospitalized for COVID-19: a single-center report. Turk J Med Sci 2020; Medetalibeyoglu A, Senkal N, Capar G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32490641

CNS (33 articles)

1. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak. ACS Chem Neurosci 2020; Yin XX, Zheng XR, Peng W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485101 2. Neuroleptic malignant syndrome in patients with COVID-19. Am J Emerg Med 2020; Soh M, Hifumi T, Isokawa S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473756 3. New onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2. Clin Microbiol Infect 2020; Patel A, Charani E, Ariyanayagam D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502645 4. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy, MRI Brain and Cerebrospinal Fluid Findings: Case 2. Cureus 2020; 12:e7930Espinosa PS, Rizvi Z, Sharma P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499974 5. Basal Ganglia Involvement and Altered Mental Status: A Unique Neurological Manifestation of Coronavirus Disease 2019. Cureus 2020; 12:e7869Haddadi K, Ghasemian R, Shafizad M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489724 6. COVID-19 Pandemic: A Neurological Perspective. Cureus 2020; 12:e7889Lahiri D, Ardila A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489743 7. Anosmia and Ageusia as the Only Indicators of Coronavirus Disease 2019 (COVID-19). Cureus 2020; 12:e7918Zhang Q, Shan KS, Abdollahi S, Nace T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494532 8. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19). Diagnosis (Berl) 2020; Lippi G, Mattiuzzi C, Bovo C, Henry BM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478675 9. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020. Emerg Infect Dis 2020; 26Benameur K, Agarwal A, Auld SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487282 10. Patient-Reported Outcome Questionnaires for the evaluation of olfactory and gustatory dysfunctions in COVID-19. Eur Arch Otorhinolaryngol 2020; Lechien JR, Hsieh J, Barillari MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494948 11. Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life. Eur Arch Otorhinolaryngol 2020; Meini S, Suardi LR, Busoni M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500326 12. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details. Eur. J. Neurol. 2020; Romoli M, Jelcic I, Bernard-Valnet R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503088 13. Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS. Front. Immunol. 2020; 11:1059Mohn N, Pul R, Kleinschnitz C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32477373 14. Temporary hyposmia in COVID-19 patients. HNO 2020; Bocksberger S, Wagner W, Hummel T et al. 15. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients? Int Forum Allergy Rhinol 2020; Marino-Sanchez F, Santamaria A, de Los Santos G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497397 16. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? Int J Mol Sci 2020; 21Archie SR, Cucullo L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486196 17. Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson's Disease in Germany. J Clin Med 2020; 9Zipprich HM, Teschner U, Witte OW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486074 18. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19). J Med Virol 2020; Baig AM, Sanders EC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492193 19. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2. J Med Virol 2020; Elgamasy S, Kamel MG, Ghozy S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484990 20. COVID-19 in teriflunomide-treated patients with multiple sclerosis. J. Neurol. 2020; Maghzi AH, Houtchens MK, Preziosa P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494856 21. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J. Neurol. 2020; Parsons T, Banks S, Bae C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474657 22. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. J Neurol Sci 2020; 415:116941Hayashi M, Sahashi Y, Baba Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474220 23. SARS-CoV2 as a potential trigger of neurodegenerative diseases. Mov Disord 2020; Gomez-Pinedo U, Matias-Guiu J, Sanclemente-Alaman I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502296 24. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead. Mov Disord 2020; Outeiro TF, Krisko A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502289 25. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection. Muscle Nerve 2020; Oguz-Akarsu E, Ozpar R, Mirzayev H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497292 26. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med 2020; Helms J, Kremer S, Merdji H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32294339 27. The neurological manifestations of COVID-19: a review article. Neurol Sci 2020; Niazkar HR, Zibaee B, Nasimi A, Bahri N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483687 28. Predicting COVID-19 Incidence Using Anosmia and Other COVID-19 Symptomatology: Preliminary Analysis Using Google and Twitter. Otolaryngol Head Neck Surg 2020:194599820932128Panuganti BA, Jafari A, MacDonald B, DeConde AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484425 29. Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks. Pharmacol. Res. 2020; 158:104917Boccanegra B, Verhaart IEC, Cappellari O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485610 30. Prevention of COVID-19 infection in the medical population: a possible help from anosmia? Rev. Recent Clin. Trials 2020; Chiarella G, Pizzonato R, Malanga D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32493200 31. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg 2020; Abboud H, Abboud FZ, Kharbouch H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474093 32. COVID-19-associated encephalitis mimicking glial tumor: a case report. World Neurosurg 2020; Efe IE, Aydin OU, Alabulut A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479911 33. Letter to the editor: Awake Craniotomy for Intracranial Gliomas during COVID-19 Pandemic. World Neurosurg 2020; Nunez-Velasco S, Mercado-Pimentel R, Rodriguez-Arias R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485243

Complications (54 articles)

1. Dysfunctional Coagulation in COVID-19: From Cell to Bedside. Adv Ther 2020; Wang J, Saguner AM, An J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504450 2. COVID-19-RELATED AORTIC THROMBOSIS: A REPORT OF FOUR CASES. Ann. Vasc. Surg. 2020; Gomez-Arbelaez D, Ibarra-Sanchez G, Garcia-Gutierrez A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474145 3. Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study. Bjog 2020; Mendoza M, Garcia-Ruiz I, Maiz N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479682 4. Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report. Chest 2020; Moores LK, Tritschler T, Brosnahan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502594 5. [Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?- Preliminary data]. Chirurg 2020; Zerwes S, Hernandez Cancino F, Liebetrau D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504106 6. Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol 2020:108487Roncati L, Ligabue G, Fabbiani L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479986 7. Abrupt deterioration and pulmonary embolism in COVID-19: a case report. Clin Med (Lond) 2020; Motwani M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503799 8. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 2020; Soy M, Keser G, Atagunduz P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474885 9. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study. Crit Care 2020; 24:275Fraisse M, Logre E, Pajot O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487122 10. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series. Crit Care 2020; 24:299Wang J, Yang Q, Zhang P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503617 11. Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients. Crit Care 2020; 24:290Wu Z, Hu R, Zhang C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503680 12. Coronavirus Disease 2019 (COVID-19) Can Masquerade as Acute Postoperative Periprosthetic Joint Infection. Cureus 2020; 12:e7857Kenanidis E, Kakoulidis P, Anagnostis P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483507 13. Refractory Acute Respiratory Distress Syndrome Secondary to COVID-19 Successfully Extubated to Average Volume-assured Pressure Support Non-invasive Ventilator. Cureus 2020; 12:e7849Mittal A, Forte M, Leonard R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483500 14. The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease. Dermatol Ther 2020:e13730Dursun R, Temiz SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475003 15. Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment. Dermatol Ther 2020; Magnano M, Balestri R, Bardazzi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475056 16. Pression-induced facial ulcers by prone position for COVID-19 mechanical ventilation. Dermatol Ther 2020; Ramondetta A, Ribero S, Costi S, Dapavo P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495445 17. Towards individualized and optimalized positioning of non-ventilated COVID-19 patients: Putting the affected parts of the lung(s) on top? Diabetes Metab. 2020; Froelich S, Mandonnet E, Julla JB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473964 18. Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model. Endocrine 2020; Mongioi LM, Barbagallo F, Condorelli RA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32488837 19. Miller-Fisher syndrome after SARS-CoV-2 infection. Eur. J. Neurol. 2020; Reyes-Bueno JA, Garcia- Trujillo L, Urbaneja P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503084 20. Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known? Fertil. Steril. 2020; 113:1140-1149Segars J, Katler Q, McQueen DB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482250 21. A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm). IDCases 2020; 21:e00829Chhetri S, Khamis F, Pandak N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483525 22. Isolated severe thrombocytopenia in a patient with COVID-19: A case report. IDCases 2020; 21:e00820Sadr S, SeyedAlinaghi S, Ghiasvand F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32483524 23. A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine. Infect Dis (Lond) 2020:1-3Maillart E, Leemans S, Van Noten H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496938 24. High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients. J Am Coll Cardiol 2020; Voicu S, Bonnin P, Stepanian A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479784 25. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro- inflammatory and anti-inflammatory cytokines. J Biol Regul Homeost Agents 2020; 34Ronconi G, Tete G, Kritas SK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476380 26. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study. J. Clin. Lab. Anal. 2020:e23415Shi M, Chen L, Yang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488958 27. COVID-19 Related Coagulopathy: A Distinct Entity? J Clin Med 2020; 9Marchandot B, Sattler L, Jesel L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486469 28. The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis. J Infect 2020; Liu M, Gao Y, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502509 29. Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19. J Infect 2020; Nguyen Y, Corre F, Honsel V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474039 30. Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: Case report. J Infect Public Health 2020; Ucpinar BA, Sahin C, Yanc U. http://www.ncbi.nlm.nih.gov/pubmed/? term=32475804 31. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care 2020; 8:36Huang I, Pranata R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483488 32. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J. Interv. Card. Electrophysiol. 2020; Gopinathannair R, Merchant FM, Lakkireddy DR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494896 33. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting. J Investig Med High Impact Case Rep 2020; 8:2324709620931239Davoodi L, Jafarpour H, Taghavi M, Razavi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493073 34. The Burden of Disease due to COVID-19 in Korea Using Disability-Adjusted Life Years. J Korean Med Sci 2020; 35:e199Jo MW, Go DS, Kim R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476305 35. Pancreatic injury in the course of coronavirus disease 2019 (COVID-19): a not-so-rare occurrence. J Med Virol 2020; Bruno G, Fabrizio C, Santoro CR, Buccoliero GB. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497298 36. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature. J Med Virol 2020; Ozaras R, Cirpin R, Duran A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497283 37. Co-infections among patients with COVID-19: The need for combination therapy with non-anti- SARS-CoV-2 agents? J Microbiol Immunol Infect 2020; Lai CC, Wang CY, Hsueh PR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482366 38. COVID-19 update: Covid-19-associated coagulopathy. J. Thromb. Thrombolysis 2020; Becker RC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32415579 39. Acute pulmonary embolism in COVID-19 related hypercoagulability. J. Thromb. Thrombolysis 2020; Lorenzo C, Francesca B, Francesco P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474757 40. Pulmonary embolism response teams in the challenging era of venous thromboembolism associated with COVID-19. J Vasc Surg Venous Lymphat Disord 2020; Porres-Aguilar M, Ayala A, Mukherjee D, Tapson VF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497628 41. Reply to "Coronaviruses and immunosuppressed patients. The facts during the third epidemic". Liver Transpl. 2020; Merli M, Perricone G, Lauterio A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32475054 42. Covid-19 and lung cancer: A greater fatality rate? Lung Cancer 2020; 146:19-22Rogado J, Pangua C, Serrano-Montero G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32505076 43. Thromboinflammatory response in SARS-CoV-2 sepsis. Med. Leg. J. 2020:25817220926915Maiese A, Passaro G, Matteis A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490726 44. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; Ackermann M, Verleden SE, Kuehnel M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32437596 45. COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 2020; Teuwen LA, Geldhof V, Pasut A, Carmeliet P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32439870 46. The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19. New Microbes New Infect 2020; 36:100697Khan FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483490 47. SARS-CoV2 RNA detection in a pancreatic pseudocyst sample. Pancreatology 2020; Schepis T, Larghi A, Papa A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498972 48. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study. Pharmacol. Res. 2020:104965Russo V, Di Maio M, Attena E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474087 49. Venous thromboembolism and COVID-19. Respir Med Res 2020; 78:100759Bertoletti L, Couturaud F, Montani D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474397 50. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res 2020; 192:152- 160Al-Ani F, Chehade S, Lazo-Langner A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485418 51. Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom. Thromb Res 2020; 193:1-4Desborough MJR, Doyle AJ, Griffiths A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485437 52. Descriptive characteristics of hospitalized adult smokers and never-smokers with COVID-19. Tob Induc Dis 2020; 18:46Kalan ME, Ghobadi H, Taleb ZB et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489343 53. Outcome of COVID-19 in Liver Transplant Recipients: a Preliminary Report from Northwestern Italy. Transpl Infect Dis 2020:e13353Patrono D, Lupo F, Canta F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32500942 54. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA). Vasa 2020:1-5Linnemann B, Bauersachs R, Grebe M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501145

Cured – Recovered (3 articles)

1. Miller-Fisher syndrome after SARS-CoV-2 infection. Eur. J. Neurol. 2020; Reyes-Bueno JA, Garcia- Trujillo L, Urbaneja P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503084 2. The issue of recurrently positive patients who recovered from COVID-19 according to the current discharge criteria: investigation of patients from multiple medical institutions in Wuhan, China. J Infect Dis 2020; Zou Y, Wang BR, Sun L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32491178 3. A More Excellent Way: Recovering Mystery in COVID Care. J Relig Health 2020; Genig JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474836

Cardiovascular disease (38 articles) 1. Lifestyle at Time of COVID-19: How Could Quarantine Affect Cardiovascular Risk. Am. J. Lifestyle Med. 2020; 14:240-242Mattioli AV, Ballerini Puviani M. http://www.ncbi.nlm.nih.gov/pubmed/? term=32477021 2. The Next Wave of Health Care Strain Related to COVID-19: Heart Failure Patients Coming Back in Force: We Must Not Fail Them. Can J Cardiol 2020; Moayedi Y, Alba AC, Lee DS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504660 3. Coronavirus Disease 2019 With Acute Respiratory Distress Syndrome Mimicking Heart Failure Exacerbation: Time to Rethink. Cardiol Res 2020; 11:196-199Sattar Y, Connerney M, Ullah W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494330 4. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction. Cardiovasc. J. Afr. 2020; 31:1-4Yolcu M, Gunesdogdu F, Bektas M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490506 5. Transcatheter mitral valve repair with MitraClip for severe mitral regurgitation and cardiogenic shock during the COVID-19 pandemic. Cardiovasc. Revasc. Med. 2020; Chitturi KR, Faza NN, Little SH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473912 6. Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circ Heart Fail 2020; Ranard LS, Fried JA, Abdalla M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500721 7. Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19. Circulation 2020; Mazzanti A, Briani M, Kukavica D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501756 8. Prevalence of COVID-19 in Out-of-Hospital Cardiac Arrest: Implications for Bystander CPR. Circulation 2020; Sayre MR, Barnard LM, Counts CR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496811 9. 31 days of COVID-19-cardiac events during restriction of public life-a comparative study. Clin Res Cardiol 2020; Rattka M, Baumhardt M, Dreyhaupt J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32494921 10. Capacity changes in German certified chest pain units during COVID-19 outbreak response. Clin Res Cardiol 2020; Settelmeier S, Rassaf T, Giannitsis E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32476041 11. Novel Coronavirus Disease 2019 and Subarachnoid Hemorrhage: A Case Report. Cureus 2020; 12:e7846Craen A, Logan G, Ganti L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483497 12. Renin-Angiotensin-System (RAS) and COVID-19 - On the Prescription of RAS Blockers. Deutsche Medizinische Wochenschrift 2020; 145:682-686Kreutz R, Abd El-Hady Algharably E, Ganten D, Messerli F. 13. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2020; Anker SD, Butler J, Khan MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498081 14. Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes. Eur. J. Cardiovasc. Nurs. 2020:1474515120934057Lauck S, Forman J, Borregaard B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498556 15. Stroke care during the Covid-19 pandemic: Experience from three large European countries. Eur. J. Neurol. 2020; Bersano A, Kraemer M, Touze E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492764 16. Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur. J. Pediatr. 2020; Sanna G, Serrau G, Bassareo PP et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474800 17. World Heart Federation Briefing on Prevention: Coronavirus Disease 2019 (COVID-19) in Low- Income Countries. Glob Heart 2020; 15:31Thienemann F, Pinto F, Grobbee DE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489804 18. Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement. Heart Lung Circ. 2020; Arnold RH, Tideman PA, Devlin GP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487432 19. Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ). Heart Lung Circ. 2020; Nicholls SJ, Nelson M, Astley C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473781 20. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality. Hypertension 2020; Zhou F, Liu YM, Xie J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493070 21. Response to the letter, "The cardiovascular burden of congenital heart disease - not only in times of COVID-19". Int J Cardiol 2020; Tan W, Aboulhosn J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473922 22. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? Int J Mol Sci 2020; 21Archie SR, Cucullo L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486196 23. Bedside Focused Cardiac Ultrasound in COVID-19 from the Wuhan Epicenter: The Role of Cardiac Point-of-Care Ultrasound, Limited Transthoracic Echocardiography, and Critical Care Echocardiography. J. Am. Soc. Echocardiogr. 2020; 33:676-682Zhang L, Wang B, Zhou J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503706 24. Acute complicated type B aortic dissection during the New York City COVID-19 surge. J. Card. Surg. 2020; Ikeda S, Shih M, Rhee RY, Youdelman BA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497341 25. The great pandemic of 2020: A defining moment for Heart Rhythm Societies and their members. J Cardiovasc Electrophysiol 2020; Lemery R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478882 26. Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin. J Cardiovasc Electrophysiol 2020; Maraj I, Hummel JP, Taoutel R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485061 27. Cardiac arrest during emergency intubation in an elderly patient with confirmed coronavirus disease 2019. J. Clin. Anesth. 2020; 66:109951Tao KM, Hu Y, Zhu XF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504963 28. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties. J Clin Med 2020; 9Schiavone M, Gobbi C, Biondi-Zoccai G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498230 29. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management. J. Diabetes Sci. Technol. 2020:1932296820930025Ceriello A, Schnell O. http://www.ncbi.nlm.nih.gov/pubmed/? term=32475168 30. COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome. J Infect 2020; Hu J, Zhang X, Zhang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474032 31. Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis. J Infect 2020; Pirola CJ, Sookoian S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474043 32. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J. Interv. Card. Electrophysiol. 2020; Gopinathannair R, Merchant FM, Lakkireddy DR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494896 33. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting. J Investig Med High Impact Case Rep 2020; 8:2324709620931239Davoodi L, Jafarpour H, Taghavi M, Razavi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493073 34. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis. J Med Virol 2020; Aikawa T, Takagi H, Ishikawa K, Kuno T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484975 35. Stroke as a complication and prognostic factor of COVID-19. Neurologia 2020; Trejo-Gabriel-Galan JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493597 36. Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations. Pharmacogenomics 2020; Snyder EM, Johnson BD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501190 37. Ischemic Stroke Epidemiology During the COVID-19 Pandemic: Navigating Uncharted Waters With Changing Tides. Stroke 2020:Strokeaha120030791Tsivgoulis G, Katsanos AH, Ornello R, Sacco S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496937 38. Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic. Trends Cardiovasc. Med. 2020; Ganatra S, Dani SS, Shah S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474135

Diagnosis (4 articles)

1. Generalized Z-numbers with hesitant fuzzy linguistic information and its application to medicine selection for the patients with mild symptoms of the COVID-19. Comput Ind Eng 2020; 145:106517Ren Z, Liao H, Liu Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501363 2. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J 2020; Gao C, Cai Y, Zhang K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498076 3. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). J. Biomed. Sci. 2020; 27:72Chang FY, Chen HC, Chen PJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498686 4. A Comprehensive Approach Is Vital for Diagnosing COVID-19: A Case of False Negative. J. Clin. Med. Res. 2020; 12:315-319Balla M, Merugu GP, Pokal M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489507

DM -MS-Obesity (20 articles)

1. Related molecular mechanisms of COVID-19, hypertension, and diabetes. Am J Physiol Endocrinol Metab 2020; 318:E881Akkus E, Sahin M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479159 2. Diabetes und Covid-19. Diabetes Aktuell 2020; 18:85Bergmann A, Schwarz PEH. 3. Challenges of diabetes care management in developing countries with a high incidence of COVID- 19: A brief report. Diabetes Metab Syndr 2020; 14:731-732Nouhjah S, Jahanfar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473905 4. Does poor glucose control increase the severity and mortality in patients with diabetes and COVID- 19? Diabetes Metab Syndr 2020; 14:725-727Singh AK, Singh R. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473903 5. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection. Diabetes Obes. Metab. 2020; Wu J, Zhang J, Sun X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496012 6. The Australian response to the COVID-19 pandemic and diabetes - lessons learned. Diabetes Res Clin Pract 2020:108246Andrikopoulos S, Johnson G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502693 7. Recommendations for management of diabetic foot ulcers during COVID-19 outbreak. Int. Wound J. 2020; Kelahmetoglu O, Camli MF, Kirazoglu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501604 8. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J. Clin. Endocrinol. Metab. 2020; Bello-Chavolla OY, Bahena-Lopez JP, Antonio-Villa NE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474598 9. A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic. J. Clin. Endocrinol. Metab. 2020; Korytkowski M, Antinori-Lent K, Drincic A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498085 10. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management. J. Diabetes Sci. Technol. 2020:1932296820930025Ceriello A, Schnell O. http://www.ncbi.nlm.nih.gov/pubmed/? term=32475168 11. COVID-19 Awakens a New Focus on Surge Capacity Blood Glucose Testing and the Critical Role of Telehealth in Self-Management. J. Diabetes Sci. Technol. 2020:1932296820930035Fantz CR, Rivers M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486964 12. COVID-19 and Diabetes: Could Diabetes Technology Research Help Pave the Way for Remote Healthcare? J. Diabetes Sci. Technol. 2020:1932296820929714Fuchs J, Hovorka R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475169 13. Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable? J. Diabetes Sci. Technol. 2020:1932296820932155Koufakis T, Metallidis S, Zebekakis P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486846 14. New Paradigms in Diabetes Management From the Epicenter. J. Diabetes Sci. Technol. 2020:1932296820930040Levy CJ, Levister CM, Shah NA. http://www.ncbi.nlm.nih.gov/pubmed/? term=32486856 15. Covid-19 and Diabetes in Hawaii. J. Diabetes Sci. Technol. 2020:1932296820931127Melish JS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486844 16. Battlefield Endocrinology. J. Diabetes Sci. Technol. 2020:1932296820930275Sadhu AR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486842 17. COVID-19: The Underestimated Pandemic Impacting People With Diabetes. J. Diabetes Sci. Technol. 2020:1932296820929389Shearer D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486884 18. COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil. J. Diabetes Sci. Technol. 2020:1932296820930033Teles M, Sacchetta T, Matsumoto Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482098 19. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? J. Endocrinol. Invest. 2020; Filardi T, Morano S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495299 20. COVID-19: a lever for the recognition of obesity as a disease? The French experience. Obesity (Silver Spring) 2020; Clement K, Coupaye M, Laville M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495493

Education and training and science (25 articles)

1. POPCoRN One-Pagers: Educational Materials for Pediatric Providers Caring For Adults. Acad. Pediatr. 2020; Lang A, Burger B, Doraiswamy V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473879 2. Service-learning in response to the coronavirus disease 2019 pandemic: Emerging lessons from the Department of Family Medicine and Public Health at the University of Botswana. Afr J Prim Health Care Fam Med 2020; 12:e1-e3Tsima BM, Masupe T, Setlhare V. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501020 3. COVID-19 Disruption in Cardiothoracic Surgical Training: An Opportunity to Enhance Education. Ann Thorac Surg 2020; Fuller S, Vaporciyan A, Dearani JA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497642 4. Contributions of dermatologists to COVID-19 research: a brief systematic review. Dermatol Ther 2020:e13713Wang Y, Fang R, Zhang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475035 5. Racism In My Medical Education. Health Aff (Millwood) 2020; 39:1087-1091Ko M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479239 6. Amplifying the role of knowledge translation platforms in the COVID-19 pandemic response. Health Res. Policy Syst. 2020; 18:58El-Jardali F, Bou-Karroum L, Fadlallah R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493339 7. [Nursing Education Strategies During the COVID-19 Epidemic]. Hu Li Za Zhi 2020; 67:96-101Hsieh HY, Hsu YY, Ko NY, Yen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495335 8. Medical and Surgical Education Challenges and Innovations in the COVID-19 Era: A Systematic Review. In Vivo 2020; 34:1603-1611Dedeilia A, Sotiropoulos MG, Hanrahan JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503818 9. Coronavirus Disease (COVID-19): A Machine Learning Bibliometric Analysis. In Vivo 2020; 34:1613- 1617F DEF, Polimeni A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503819 10. Considerations for Underrepresented in Medicine Dermatology Residency Applicants Amidst the COVID-19 Pandemic. J Am Acad Dermatol 2020; Jones VA, Clark KA, Patel PM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504722 11. Strategic Deployment of Cardiology Fellows-in-Training Using the Accreditation Council for Graduate Medical Education COVID-19 Framework. J Am Heart Assoc 2020:e017443Gallagher MJ, Bloomingdale R, Berman AD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476547 12. The future of business education: A commentary in the shadow of the Covid-19 pandemic. J Bus Res 2020; 117:1-5Krishnamurthy S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501309 13. Medical education in the COVID-19 era: Impact on anesthesiology trainees. J. Clin. Anesth. 2020; 66:109949Anwar A, Seger C, Tollefson A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504968 14. Disruptions during a pandemic: Gaps identified and lessons learned. J. Dent. Educ. 2020; Elangovan S, Mahrous A, Marchini L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500586 15. SARS-CoV-2 Human Challenge Trials: Too Risky, Too Soon. J Infect Dis 2020; Dawson L, Earl J, Livezey J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496536 16. Impact of COVID-19 pandemic on medical postgraduate training in the United States. Med. Educ. Online 2020; 25:1774318Edigin E, Eseaton PO, Shaka H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32493181 17. Peer teaching medical students during a pandemic. Med. Educ. Online 2020; 25:1772014Roberts V, Malone K, Moore P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493174 18. Rapid publishing in the era of coronavirus disease 2019 (COVID-19). Med. J. Aust. 2020; Lee AY, Lin MW. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474929 19. Rapid publishing in the era of coronavirus disease 2019 (COVID-19). Med. J. Aust. 2020; Talley NJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474933 20. COVID-19: Are Spanish medicine and nursing students prepared? Nurse Educ. Today 2020; 92:104473Cervera-Gasch A, Gonzalez-Chorda VM, Mena-Tudela D. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497867 21. Nursing education in a pandemic: Academic challenges in response to COVID-19. Nurse Educ. Today 2020; 92:104471Dewart G, Corcoran L, Thirsk L, Petrovic K. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502723 22. Effect of Implementing Simulation Education on Health Care Worker Comfort With Nasopharyngeal Swabbing for COVID-19. Otolaryngol Head Neck Surg 2020:194599820933168Mark ME, LoSavio P, Husain I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482155 23. Impact of the COVID-19 Pandemic on the Urology Residency Match in Singapore. Urology 2020; Tan YQ, Pek XWG, Wang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504688 24. The Good, the Bad, and the Ugly of the COVID-19 Pandemic in a Urology Residency Program in Singapore. Urology 2020; Tan YQ, Wang Z, Tiong HY, Chiong E. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473937 25. Challenges to Neurosurgical Residency Training during COVID-19 Pandemic: An Indian Perspective. World Neurosurg 2020; Ruparelia J, Gosal JS, Garg M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474090

Elderly (15 articles)

1. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages. Aging (Albany NY) 2020; 12Zhao M, Wang M, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499448 2. Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19. Int J Infect Dis 2020; Li P, Chen L, Liu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492533 3. Mental health of older adults during the COVID-19 pandemic: lessons from history to guide our future. Int. Psychogeriatr. 2020:1-4Chong TWH, Curran E, Ames D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489166 4. Local Government Efforts to Mitigate the Novel Coronavirus Pandemic among Older Adults. J Aging Soc Policy 2020:1-11Angel JL, Mudrazija S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501753 5. "We are Alone in This Battle": A Framework for a Coordinated Response to COVID-19 in Nursing Homes. J Aging Soc Policy 2020:1-7Behrens LL, Naylor MD. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497467 6. Six Propositions against Ageism in the COVID-19 Pandemic. J Aging Soc Policy 2020:1-11Ehni HJ, Wahl HW. http://www.ncbi.nlm.nih.gov/pubmed/?term=32491963 7. The Unique Impact of COVID-19 on Older Adults in Rural Areas. J Aging Soc Policy 2020:1-7Henning- Smith C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475255 8. COVID-19 and Long-Term Care Policy for Older People in Hong Kong. J Aging Soc Policy 2020:1- 7Lum T, Shi C, Wong G, Wong K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476597 9. Meeting the Transitional Care Needs of Older Adults with COVID-19. J Aging Soc Policy 2020:1- 9Naylor MD, Hirschman KB, McCauley K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476586 10. Effectively Engaging Geriatric Patients via Teledermatology. J Am Acad Dermatol 2020; Simpson CL, Kovarik CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497703 11. COVID-19 Pandemic: Workforce Implications for Gerontological Social Work. J Gerontol Soc Work 2020:1-6Berg-Weger M, Schroepfer T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501174 12. Older Workers in the Time of COVID-19: The Senior Community Service Employment Program and Implications for Social Work. J Gerontol Soc Work 2020:1-12Halvorsen CJ, Yulikova O. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501142 13. Geriatric Health in Bangladesh during COVID-19: Challenges and Recommendations. J Gerontol Soc Work 2020:1-4Hossain MM, Mazumder H, Tasnim S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501147 14. SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes. J Infect 2020; Graham N, Junghans C, Downes R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32504743 15. Epidemiological Evidence for Association between Higher Influenza Vaccine Uptake in the Elderly and Lower COVID-19 Deaths in Italy. J Med Virol 2020; Marin-Hernandez D, Schwartz RE, Nixon DF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497290

Epidemiology (126 articles)

1. Leveraging investments in Ebola preparedness for COVID-19 in Sub-Saharan Africa. AAS Open Res 2020; 3:3Ayebare R, Waitt P, Okello S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500116 2. Drive-Through COVID-19 Testing During the 2020 Pandemic: a safe, efficient, and scalable model for pediatric patients and healthcare workers. Acad. Pediatr. 2020; Flynn EF, Kuhn E, Shaik M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479895 3. [How Acta Medica Portuguesa Adjusted to Pandemic Times]. Acta Med Port 2020; 33:357- 358Villanueva T, Donato H, Escada P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504509 4. Community-based screening and testing for Coronavirus in Cape Town, South Africa: Short report. Afr J Prim Health Care Fam Med 2020; 12:e1-e3David N, Mash R. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501021 5. COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity? Aging Dis 2020; 11:480-488Chakrabarti SS, Kaur U, Banerjee A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489695 6. Novel Coronavirus Disease and the Current Scenario of the Global Health Emergency. Antiinflamm. Antiallergy Agents Med. Chem. 2020; Baruah G, Sahu J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32479247 7. Population vulnerability to COVID-19 in Europe: a burden of disease analysis. Arch Public Health 2020; 78:47Wyper GMA, Assuncao R, Cuschieri S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501409 8. COVID-19-A Novel Zoonotic Disease: A Review of the Disease, the Virus, and Public Health Measures. Asia Pac. J. Public Health 2020:1010539520931326Mackenzie JS, Smith DW. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475144 9. Heterogenous COVID-19 transmission dynamics within Singapore: a clearer picture of future national responses. BMC Med 2020; 18:164Bagdasarian N, Fisher D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493311 10. Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020. BMC Med 2020; 18:166Tariq A, Lee Y, Roosa K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493466 11. COVID-19 pandemic: a viewpoint from Asia. Bull Natl Res Cent 2020; 44:80Abdullah-Al-Shafi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501384 12. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients. Cell 2020; Bost P, Giladi A, Liu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479746 13. Forecast and evaluation of COVID-19 spreading in USA with reduced-space Gaussian process regression. Chaos Solitons Fractals 2020; 136:109924Arias Velasquez RM, Mejia Lara JV. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501372 14. Modelling the spread of COVID-19 with new fractal-fractional operators: Can the lockdown save mankind before vaccination? Chaos Solitons Fractals 2020; 136:109860Atangana A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501371 15. A multi-group SEIRA model for the spread of COVID-19 among heterogeneous populations. Chaos Solitons Fractals 2020; 136:109925Contreras S, Villavicencio HA, Medina-Ortiz D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501373 16. COVID-19 created chaos across the globe: Three novel quarantine epidemic models. Chaos Solitons Fractals 2020; 138:109928Mishra BK, Keshri AK, Rao YS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501378 17. Estimation of COVID-19 dynamics "on a back-of-envelope": Does the simplest SIR model provide quantitative parameters and predictions? Chaos Solitons Fractals 2020; 135:109841Postnikov EB. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501369 18. Short-term forecasting COVID-19 cumulative confirmed cases: Perspectives for Brazil. Chaos Solitons Fractals 2020; 135:109853Ribeiro M, da Silva RG, Mariani VC, Coelho LDS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501370 19. Lessons from being challenged by COVID-19. Chaos Solitons Fractals 2020; 137:109923Tagliazucchi E, Balenzuela P, Travizano M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501375 20. Statistical analysis of forecasting COVID-19 for upcoming month in Pakistan. Chaos Solitons Fractals 2020; 138:109926Yousaf M, Zahir S, Riaz M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501377 21. SARS-CoV-2/COVID-19 and physical distancing: risk for circadian rhythm dysregulation, advice to alleviate it, and natural experiment research opportunities. Chronobiol. Int. 2020:1-4Erren TC, Lewis P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498625 22. Emerging study on the transmission of the Novel Coronavirus (COVID-19) from urban perspective: Evidence from China. Cities 2020; 103:102759Liu L. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501355 23. COVID-19 pandemic: Impact caused by school closure and national lockdown on pediatric visits and admissions for viral and non-viral infections, a time series analysis. Clin Infect Dis 2020; Angoulvant F, Ouldali N, Yang DD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492117 24. The natural history and transmission potential of asymptomatic SARS-CoV-2 infection. Clin Infect Dis 2020; Chau NVV, Thanh Lam V, Thanh Dung N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497212 25. From Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality. Clin Infect Dis 2020; Nachega JB, Grimwood A, Mahomed H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474594 26. COVID-19 outbreaks in U.S. immigrant detention centers: the urgent need to adopt CDC guidelines for prevention and evaluation. Clin Infect Dis 2020; Openshaw JJ, Travassos MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474574 27. Monitoring COVID-19 through Trends in Influenza-like Illness and Laboratory-confirmed Influenza and COVID-19 - New York State, excluding New York City, January 1 - April 12, 2020. Clin Infect Dis 2020; Rosenberg ES, Hall EW, Rosenthal EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474578 28. COVID-19 Outbreak Response for an Emergency Department Using In Situ Simulation. Cureus 2020; 12:e7876Jee M, Khamoudes D, Brennan AM, O'Donnell J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489730 29. Novel wastewater surveillance strategy for early detection of coronavirus disease 2019 hotspots. Curr Opin Environ Sci Health 2020; 17:8-13Venugopal A, Ganesan H, Sudalaimuthu Raja SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501429 30. The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev. 2020; Hiscott J, Alexandridi M, Muscolini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487439 31. Epidemiology and control of COVID-19. Deutsche Medizinische Wochenschrift 2020; 145:670-674Müller O, Neuhann F, Razum O. 32. COVID-19-Response - Strategies of the Task-Force Coronavirus and experiences upon implementation in the management of 115 cases at the University Medical Center Freiburg. Deutsche Medizinische Wochenschrift 2020; 145:657-664Rieg S, Busch HJ, Hans F et al. 33. Emergency Medicine's COVID Future: facing the triple challenge after flattening the curve. Emerg. Med. Australas. 2020; Staib A, Small N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484307 34. COVID-19, internists and resilience: the north-south Italy outbreak. Eur. J. Clin. Invest. 2020:e13299Di Ciaula A, Palmieri VO, Migliore G, Portincasa P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480424 35. Adaptation to SARS-CoV-2 under stress: Role of distorted information. Eur. J. Clin. Invest. 2020:e13294Sharov KS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474908 36. The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic. Eur J Heart Fail 2020; Bromage DI, Cannata A, Rind IA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478951 37. Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020. Euro Surveill 2020; 25Augustin M, Schommers P, Suarez I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489176 38. No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020. Euro Surveill 2020; 25Heavey L, Casey G, Kelly C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489179 39. Czech Republic and low COVID-19 mortality in the heart of Europe: possible explanations. European Heart Journal 2020; Celko AM, Benes J, Widimsky P. 40. Linking key intervention timings to rapid declining effective reproduction number to quantify lessons against COVID-19. Front Med 2020; Peng Z, Song W, Ding Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495288 41. In the shadow of HIV & TB: A commentary on the COVID epidemic in South Africa. Glob Public Health 2020:1-13Bulled N, Singer M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486906 42. Incarceration And Its Disseminations: COVID-19 Pandemic Lessons From Chicago's Cook County Jail. Health Aff (Millwood) 2020:101377hlthaff202000652Reinhart E, Chen D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496864 43. Are We Ready For The Next Pandemic? Health Aff (Millwood) 2020; 39:1104Torbay R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479216 44. The crucible of COVID-19: what the pandemic is teaching us about health research systems. Health Res. Policy Syst. 2020; 18:52Turner T, El-Jardali F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487103 45. Analysis of Outbreak and Global Impacts of the COVID-19. Healthcare (Basel) 2020; 8Priyadarshini I, Mohanty P, Kumar R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485875 46. [The War Against the Coronavirus Disease (COVID-2019): Keys to Successfully Defending Taiwan]. Hu Li Za Zhi 2020; 67:75-83Huang WT, Chen YY. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495332 47. [Nurses: A Voice to Lead, Nursing the World to Health-Viewing COVID-19 Epidemic Prevention Efforts in Light of Nightingale's Perspective on Infection Control]. Hu Li Za Zhi 2020; 67:102-110Peng MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495336 48. Novel Coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries. Hum Vaccin Immunother 2020:1-3Anjum FR, Anam S, Rahman SU. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501130 49. Lockdown During COVID-19: The Greek Success. In Vivo 2020; 34:1695-1699Moris D, Schizas D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503831 50. A cluster of SARS-CoV-2 infection among Italian tourists visiting India, March 2020. Indian J Med Res 2020; Vivian Thangaraj JW, Murhekar M, Mehta Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474558 51. Impact of lockdown following COVID-19 on the gaming behavior of college students. Indian J. Public Health 2020; 64:S172-s176Balhara YPS, Kattula D, Singh S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496250 52. The armed forces medical services response to COVID-19. Indian J. Public Health 2020; 64:S94- s95Banerji A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496233 53. Distribution and growth rate of COVID-19 outbreak in Tamil Nadu: A log-linear regression approach. Indian J. Public Health 2020; 64:S188-s191Bhaskar A, Ponnuraja C, Srinivasan R, Padmanaban S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496253 54. Community preparedness for COVID-19 and frontline health workers in Chhattisgarh. Indian J. Public Health 2020; 64:S102-s104Chatterjee PK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496236 55. How Indians responded to the Arogya Setu app? Indian J. Public Health 2020; 64:S228-s230Kodali PB, Hense S, Kopparty S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496261 56. Significance of super spreader events in COVID-19. Indian J. Public Health 2020; 64:S139-s141Kumar S, Jha S, Rai SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496245 57. Effectiveness of preventive measures against COVID-19: A systematic review of In Silico modeling studies in indian context. Indian J. Public Health 2020; 64:S156-s167Lahiri A, Jha SS, Bhattacharya S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496248 58. Insights from COVID-19 cluster containment in Bhilwara District, Rajasthan. Indian J. Public Health 2020; 64:S177-s182Meghwal B, Behera S, Dhariwal AC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496251 59. A science-based response to COVID-19. Indian J. Public Health 2020; 64:S90Muliyil JP. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496231 60. Impact of nonpharmacological interventions on COVID-19 transmission dynamics in India. Indian J. Public Health 2020; 64:S142-s146Patel P, Athotra A, Vaisakh TP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496246 61. Kerala's response to COVID-19. Indian J. Public Health 2020; 64:S99-s101Sadanandan R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496235 62. Containing the first outbreak of COVID-19 in a healthcare setting in India: The sree chitra experience. Indian J. Public Health 2020; 64:S240-s242Singh G, Srinivas G, Jyothi EK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496265 63. Health systems preparedness for COVID-19 pandemic. Indian J. Public Health 2020; 64:S91- s93Sundararaman T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496232 64. An epidemiological study of laboratory confirmed COVID-19 cases admitted in a tertiary care hospital of Pune, Maharashtra. Indian J. Public Health 2020; 64:S183-s187Tambe MP, Parande MA, Tapare VS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496252 65. Lack of transparency during the COVID-19: nurturing a future and more devastating crisis. Infect Control Hosp Epidemiol 2020:1-3Braillon A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489164 66. SARS-CoV-2: The viral shedding vs infectivity dilemma. Infect Dis Health 2020; Widders A, Broom A, Broom J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473952 67. The Greek Response to COVID-19: A True Success Story from an IBD Perspective. Inflamm. Bowel Dis. 2020; Bamias G, Lagou S, Gizis M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476001 68. COVID-19 Outbreak in North Italy: An Overview on Dentistry. A Questionnaire Survey. Int J Environ Res Public Health 2020; 17Cagetti MG, Cairoli JL, Senna A, Campus G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32481672 69. Sociodemographic Predictors of Health Risk Perception, Attitude and Behavior Practices Associated with Health-Emergency Disaster Risk Management for Biological Hazards: The Case of COVID-19 Pandemic in Hong Kong, SAR China. Int J Environ Res Public Health 2020; 17Chan EYY, Huang Z, Lo ESK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485979 70. Forecast Possible Risk for COVID-19 Epidemic Dissemination Under Current Control Strategies in Japan. Int J Environ Res Public Health 2020; 17Chen Z, Yang J, Dai B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486011 71. Spatial Statistics and Influencing Factors of the COVID-19 Epidemic at Both Prefecture and County Levels in Hubei Province, China. Int J Environ Res Public Health 2020; 17Xiong Y, Wang Y, Chen F, Zhu M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486403 72. A Comparison of Infection Venues of COVID-19 Case Clusters in Northeast China. Int J Environ Res Public Health 2020; 17Zhao P, Zhang N, Li Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503192 73. Inequalities in access to water and soap matter for the COVID-19 response in sub-Saharan Africa. Int J Equity Health 2020; 19:82Jiwani SS, Antiporta DA. http://www.ncbi.nlm.nih.gov/pubmed/? term=32493409 74. Air Pollution and temperature are associated with increased COVID-19 incidence: a time series study. Int J Infect Dis 2020; Li H, Xu XL, Dai DW et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502664 75. COVID-19 Outbreak in Malaysia: Actions Taken by the Malaysian Government. Int J Infect Dis 2020; Shah AUM, Safri SNA, Thevadas R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497808 76. Early characteristics of the COVID-19 outbreak predict the subsequent epidemic size. Int J Infect Dis 2020; Zhang L, Tao Y, Wang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502662 77. Coronavirus disease 2019 (COVID-19): strengthening our resolve to achieve universal palliative care. Int Nurs Rev 2020; Rosa WE, Davidson PM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495339 78. Risk of a second wave of Covid-19 infections: using artificial intelligence to investigate stringency of physical distancing policies in North America. Int. Orthop. 2020; Vaid S, McAdie A, Kremer R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504213 79. Local Government Efforts to Mitigate the Novel Coronavirus Pandemic among Older Adults. J Aging Soc Policy 2020:1-11Angel JL, Mudrazija S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501753 80. COVID-19 Pandemic: Exacerbating Racial/Ethnic Disparities in Long-Term Services and Supports. J Aging Soc Policy 2020:1-11Shippee TP, Akosionu O, Ng W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32476614 81. Characteristics of U.S. Nursing Homes with COVID-19 Cases. J Am Geriatr Soc 2020; Abrams HR, Loomer L, Gandhi A, Grabowski DC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484912 82. The role of asymptomatic class, quarantine and isolation in the transmission of COVID-19. J. Biol. Dyn. 2020; 14:389-408Ali M, Shah STH, Imran M, Khan A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32498655 83. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study. J Clin Virol 2020; 129:104475Yang L, Liu J, Zhang R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485619 84. Epidemiology of the 2020 Pandemic of COVID-19 in the State of Texas: The First Month of Community Spread. J. Community Health 2020; Khose S, Moore JX, Wang HE. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500438 85. COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil. J. Diabetes Sci. Technol. 2020:1932296820930033Teles M, Sacchetta T, Matsumoto Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482098 86. Early SNS-based monitoring system for the COVID-19 outbreak in Japan: a population-level observational study. J. Epidemiol. 2020; Yoneoka D, Kawashima T, Tanoue Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475884 87. Practical Implications of Physical Distancing, Social Isolation, and Reduced Physicality for Older Adults in Response to COVID-19. J Gerontol Soc Work 2020:1-3Campbell AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501151 88. Clinical assessment of COVID-19 outbreak among migrant workers residing in a large dormitory in Singapore. J Hosp Infect 2020; Chew MH, Koh FH, Wu JT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32492454 89. High SARS-CoV-2 Antibody Prevalence among Healthcare Workers Exposed to COVID-19 Patients. J Infect 2020; Chen Y, Tong X, Wang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504745 90. Dynamic variations of the COVID-19 disease at different quarantine strategies in Wuhan and mainland China. J Infect Public Health 2020; Cui Q, Hu Z, Li Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32493669 91. Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA. J. Intellect. Disabil. Res. 2020; Mills WR, Sender S, Lichtefeld J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490559 92. Letter to the Editor: Assessing the Long-Term Potential of Relaxing Regulations: Should We Go Back to Business as Usual? J. Laparoendosc. Adv. Surg. Tech. A 2020; Jabbour N, Carlis A, Orthopoulos G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498653 93. Quantifying the role of social distancing, personal protection and case detection in mitigating COVID-19 outbreak in Ontario, Canada. J Math Ind 2020; 10:15Wu J, Tang B, Bragazzi NL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501416 94. Considerations for an Individual-Level Population Notification System for Pandemic Response: A Review and Prototype. J Med Internet Res 2020; 22:e19930Sakib MN, Butt ZA, Morita PP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484443 95. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol 2020; Lotfi M, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492197 96. OVERCOMING THE COVID-19 CRISIS AND PLANING FOR THE FUTURE. J Nucl Med 2020; LoGiudice SH, Liebhaber A, Schoder H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482789 97. Estimate of the Basic Reproduction Number for COVID-19: A Systematic Review and Meta-analysis. J Prev Med Public Health 2020; 53:151-157Alimohamadi Y, Taghdir M, Sepandi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498136 98. Characteristics of the COVID-19 Outbreak in Korea From the Mass Infection Perspective. J Prev Med Public Health 2020; 53:168-170Kang YJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498139 99. Forecasting COVID-19 Transmission and Healthcare Capacity in Bali, Indonesia. J Prev Med Public Health 2020; 53:158-163Wirawan IMA, Januraga PP. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498137 100. Racial disparities in knowledge, attitudes and practices related to COVID-19 in the USA. J Public Health (Oxf) 2020; Alobuia WM, Dalva-Baird NP, Forrester JD et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32490519 101. The Faith Community and the SARS-CoV-2 Outbreak: Part of the Problem or Part of the Solution? J Relig Health 2020; Levin J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488827 102. Exposure to SARS-CoV-2 in a high transmission setting increases the risk of severe COVID-19 compared to exposure to a low transmission setting? J Travel Med 2020; Chen D, Hu C, Su F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502262 103. The potential transmission of SARS-CoV-2 from patients with negative RT-PCR swab tests to others: two related clusters of COVID-19 outbreak. Jpn. J. Infect. Dis. 2020; Cao G, Tang S, Yang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475877 104. Epidemic characteristics of COVID-19 in four Chinese cities. Jpn. J. Infect. Dis. 2020; Hu J, Rao S, Hu X. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475873 105. A Case of COVID-19 Patient with False-negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese traveller Returning from Wuhan, Hubei Province, China, January 2020. Jpn. J. Infect. Dis. 2020; Ishikane M, Miyazato Y, Kustuna S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475881 106. A Survey of County Health Departments of Kansas Regarding COVID-19. Kans J Med 2020; 13:112- 126Raghuveer TS, Zackula RE, Wittler RR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499864 107. A data-driven network model for the emerging COVID-19 epidemics in Wuhan, Toronto and Italy. Math. Biosci. 2020:108391Xue L, Jing S, Miller JC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497623 108. From SARS to COVID-19: the Singapore journey. Med. J. Aust. 2020; Lin RJ, Lee TH, Lye DC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474940 109. A survey on the impact of the COVID-19 pandemic on motility and functional investigations in Europe and considerations for recommencing activities in the early recovery phase. Neurogastroenterol. Motil. 2020:e13926Tack J, Schol J, Geeraerts A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478910 110. Epidemiologic character of COVID-19 in Kazakhstan: A preliminary report. North Clin Istanb 2020; 7:210-213Maukayeva S, Karimova S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478290 111. The Impact of Social Distancing on the Transmission of Influenza Virus, South Korea, 2020. Osong Public Health Res Perspect 2020; 11:91-92Choe YJ, Lee JK. http://www.ncbi.nlm.nih.gov/pubmed/? term=32494566 112. COVID-19 Outbreak in Malaysia. Osong Public Health Res Perspect 2020; 11:93-100Elengoe A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494567 113. Forecasting the prevalence of COVID-19 outbreak in Egypt using nonlinear autoregressive artificial neural networks. Process Saf Environ Prot 2020; 141:1-8Saba AI, Elsheikh AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501368 114. Modeling compliance with COVID-19 prevention guidelines: the critical role of trust in science. Psychol Health Med 2020:1-12Plohl N, Musil B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479113 115. COVID-19 spread: The Italian case. Respir Med Res 2020; 78:100771Harari S, Vitacca M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502937 116. Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID. Sci Total Environ 2020; 729:138474Coccia M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498152 117. Wastewater surveillance for population-wide Covid-19: The present and future. Sci Total Environ 2020; 736:139631Daughton CG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474280 118. COVID-19's impact on the atmospheric environment in the Southeast Asia region. Sci Total Environ 2020; 736:139658Kanniah KD, Kamarul Zaman NAF, Kaskaoutis DG, Latif MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492613 119. Temperature and precipitation associate with Covid-19 new daily cases: A correlation study between weather and Covid-19 pandemic in Oslo, Norway. Sci Total Environ 2020; 737:139659Menebo MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492607 120. Statistical Explorations and Univariate Timeseries Analysis on COVID-19 Datasets to Understand the Trend of Disease Spreading and Death. Sensors (Basel) 2020; 20Chatterjee A, Gerdes MW, Martinez SG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486055 121. Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China. Theor. Biol. Med. Model. 2020; 17:9Kim S, Choi S, Ko Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498721 122. Exploring the roles of high-speed train, air and coach services in the spread of COVID-19 in China. Transp Policy (Oxf) 2020; 94:34-42Zhang Y, Zhang A, Wang J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501380 123. Contact tracing: a lesson from the Nipah virus in the time of COVID-19. Trop. Doct. 2020:49475520928217Wilson A, Warrier A, Rathish B. http://www.ncbi.nlm.nih.gov/pubmed/? term=32476600 124. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]. Vopr. Virusol. 2020; 65:6-15Lvov DK, Alkhovsky SV, Kolobukhina LV, Burtseva EI. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496715 125. Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment. Wellcome Open Res 2020; 5:81Ainslie KEC, Walters CE, Fu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500100 126. Disability-inclusive COVID-19 response: What it is, why it is important and what we can learn from the United Kingdom's response. Wellcome Open Res 2020; 5:79Kuper H, Banks LM, Bright T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500099

Gastro-enterology-hepatology (20 articles)

1. Coronavirus disease 2019 (COVID-19) and ischemic colitis: An under-recognized complication. Am J Emerg Med 2020; Chan KH, Lim SL, Damati A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499176 2. Gastrointestinal endoscopy operation--A potential transmission risk for SARS-CoV-2. Am. J. Infect. Control 2020; Tan C, Xiao Y, Wu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485277 3. Improved safety of endoscopic vessel harvesting during the COVID-19 pandemic. Ann Thorac Surg 2020; Ali Hassan SM, Palacios CM, Ethier T, Bisleri G. http://www.ncbi.nlm.nih.gov/pubmed/? term=32504604 4. [Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?- Preliminary data]. Chirurg 2020; Zerwes S, Hernandez Cancino F, Liebetrau D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504106 5. ENDOSCOPIC FINDINGS IN PATIENTS INFECTED WITH 2019 NOVEL CORONAVIRUS IN LOMBARDY, ITALY. Clin Gastroenterol Hepatol 2020; Massironi S, Vigano C, Dioscoridi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480008 6. Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study. Clin Gastroenterol Hepatol 2020; Rigamonti C, Cittone MG, De Benedittis C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480009 7. Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis. Clin Res Hepatol Gastroenterol 2020; Zhai LL, Xiang F, Wang W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482542 8. The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons. Dis. Esophagus 2020; Kamarajah SK, Markar SR, Singh P, Griffiths EA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500134 9. Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease. Gastroenterology 2020; Lukin DJ, Kumar A, Hajifathalian K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479824 10. Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey. Inflamm. Bowel Dis. 2020; Martin Arranz E, Suarez Ferrer C, Garcia Ramirez L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495826 11. COVID 19 and laparoscopic surgeons, the Indian scenario - Perspective. Int J Surg 2020; Gupta N, Agrawal H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479915 12. Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice. Intest Res 2020; Chen Y, Yu Q, Farraye FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475088 13. Development and Validation of a Clinical Risk Score for Intensive Care Resource Utilization After Colon Cancer Surgery: a Practical Guide to the Selection of Patients During COVID-19. J Gastrointest Surg 2020; Garfinkle R, Abou-Khalil M, Salama E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495141 14. SARS-CoV-2: is the liver merely a bystander to severe disease? J Hepatol 2020; Bangash MN, Patel JM, Parekh D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502510 15. Indian Association of Gastrointestinal Endo Surgeons COVID-19 endoscopy recommendations. J. Minim. Access Surg. 2020; 16:201-205Sundaram E, Manickavasagam K, Goel R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503959 16. SARS-CoV-2 Infection and the Liver. Pathogens 2020; 9Morgan K, Samuel K, Vandeputte M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486188 17. Outcome of COVID-19 in Liver Transplant Recipients: a Preliminary Report from Northwestern Italy. Transpl Infect Dis 2020:e13353Patrono D, Lupo F, Canta F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32500942 18. [Surgery during the SARS-CoV-2 pandemic : Recommendations on operative procedures]. Unfallchirurg 2020; Mahlke L, Flohe S, Matthes G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32488319 19. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J. Gastroenterol. 2020; 26:2323-2332Cha MH, Regueiro M, Sandhu DS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476796 20. Liver diseases in COVID-19: Etiology, treatment and prognosis. World J. Gastroenterol. 2020; 26:2286- 2293Wu J, Song S, Cao HC, Li LJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476793

Guidelines -Consensus (18 articles)

1. Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report. Chest 2020; Moores LK, Tritschler T, Brosnahan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502594 2. Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens. Curr Protoc Cytom 2020; 93:e77Bain W, Lee JS, Watson AM, Stitt-Fischer MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502333 3. Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings. Diabetes Metab Syndr 2020; 14:753-756Goyal A, Gupta S, Gupta Y, Tandon N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502958 4. Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2020; Herman P, Vincent C, Parietti Winkler C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482571 5. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2020; Anker SD, Butler J, Khan MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498081 6. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2020:2047487320930596Bhatia RT, Marwaha S, Malhotra A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32475157 7. Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement. Heart Lung Circ. 2020; Arnold RH, Tideman PA, Devlin GP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487432 8. Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ). Heart Lung Circ. 2020; Nicholls SJ, Nelson M, Astley C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473781 9. ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology. J. Am. Soc. Echocardiogr. 2020; 33:648-653Kirkpatrick JN, Mitchell C, Taub C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503700 10. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic. J Eur Acad Dermatol Venereol 2020; Chernyshov PV, Tomas-Aragones L, Augustin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498128 11. Development and Validation of a Clinical Risk Score for Intensive Care Resource Utilization After Colon Cancer Surgery: a Practical Guide to the Selection of Patients During COVID-19. J Gastrointest Surg 2020; Garfinkle R, Abou-Khalil M, Salama E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495141 12. ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic. J. Med. Toxicol. 2020; Stolbach AI, Mazer-Amirshahi M, Marino R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500283 13. Indian Association of Gastrointestinal Endo Surgeons COVID-19 endoscopy recommendations. J. Minim. Access Surg. 2020; 16:201-205Sundaram E, Manickavasagam K, Goel R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503959 14. COVID-19: Preliminary Clinical Guidelines for Ophthalmology Practices. Med Hypothesis Discov Innov Ophthalmol 2020; 9:149-158Gharebaghi R, Desuatels J, Moshirfar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490022 15. A Guiding Principles Checklist for Otolaryngologic Surgery in the COVID-19 Era. Otolaryngol Head Neck Surg 2020:194599820933253Valika TS, Maurrasse SE, Thompson DM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482124 16. Chinese Society of Interventional Radiology Expert Consensus on the prevention and control of COVID-19 in interventional radiology procedures (first edition). Quant Imaging Med Surg 2020; 10:1045-1057Zhu Y, He Y, Wang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489928 17. Recommendations of the Thoracic Imaging Section of the German Radiological Society for clinical application of chest imaging and structured CT reporting in the COVID-19 pandemic. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2020; Vogel-Claussen J, Ley- Zaporozhan J, Agarwal P et al. 18. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA). Vasa 2020:1-5Linnemann B, Bauersachs R, Grebe M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501145

Imaging (21 articles)

1. Systematic Review and Meta-Analysis on the Value of Chest CT in the Diagnosis of Coronavirus Disease (COVID-19): Sol Scientiae, Illustra Nos. AJR Am J Roentgenol 2020:1-9Adams HJA, Kwee TC, Yakar D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478562 2. Lung ultrasound monitoring in patients with COVID-19 on home isolation. Am J Emerg Med 2020; Shokoohi H, Duggan NM, Garcia-de-Casasola Sanchez G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32482483 3. The role of pulmonary CT scans for children during the COVID-19 pandemic. BMC Med 2020; 18:171Sinha IP, Kaleem M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498685 4. Incidental CT findings in the lungs in COVID-19 patients presenting with abdominal pain. Clin Imaging 2020; 67:1-4Voutsinas N, Toussie D, Jacobi A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32492557 5. Weakly Labeled Data Augmentation for Deep Learning: A Study on COVID-19 Detection in Chest X- Rays. Diagnostics (Basel) 2020; 10Rajaraman S, Antani S. http://www.ncbi.nlm.nih.gov/pubmed/? term=32486140 6. Point-of-care lung ultrasound in three neonates with COVID-19. Eur. J. Pediatr. 2020; Gregorio- Hernandez R, Escobar-Izquierdo AB, Cobas-Pazos J, Martinez-Gimeno A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504135 7. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients. Eur Radiol 2020; Ojha V, Mani A, Pandey NN et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474632 8. Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms. Eur Radiol 2020; Vancheri SG, Savietto G, Ballati F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474630 9. COVID-19 Incidentally Detected on PET/CT During Work-up for Locally Advanced Head and Neck Cancer. In Vivo 2020; 34:1681-1684Mo A, Brodin NP, Tome WA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503829 10. A modified deep convolutional neural network for detecting COVID-19 and pneumonia from chest X- ray images based on the concatenation of Xception and ResNet50V2. Inform Med Unlocked 2020; 19:100360Rahimzadeh M, Attar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501424 11. ASE Statement on Point-of-Care Ultrasound during the 2019 Novel Coronavirus Pandemic. J. Am. Soc. Echocardiogr. 2020; 33:670-673Johri AM, Galen B, Kirkpatrick JN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503704 12. Bedside Focused Cardiac Ultrasound in COVID-19 from the Wuhan Epicenter: The Role of Cardiac Point-of-Care Ultrasound, Limited Transthoracic Echocardiography, and Critical Care Echocardiography. J. Am. Soc. Echocardiogr. 2020; 33:676-682Zhang L, Wang B, Zhou J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503706 13. Clinical Potential of UTE-MRI for Assessing COVID-19: Patient- and Lesion-Based Comparative Analysis. J. Magn. Reson. Imaging 2020; Yang S, Zhang Y, Shen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32491257 14. Lung Ultrasound Can Influence the Clinical Treatment of Pregnant Women With COVID-19. J Ultrasound Med 2020; Yassa M, Birol P, Mutlu AM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32478445 15. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. J Xray Sci Technol 2020; Wei J, Lei P, Yang H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474479 16. Coronavirus disease 2019: initial high resolution computed tomography imaging feature analysis: report of seven cases. Jpn. J. Infect. Dis. 2020; Huang J, Ding J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32475876 17. A systematic review of chest imaging findings in COVID-19. Quant Imaging Med Surg 2020; 10:1058- 1079Sun Z, Zhang N, Li Y, Xu X. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489929 18. Radiology of COVID-19 Pneumonia - Pictorial Essay and Structured Reporting. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2020; 192:513-517Schaible J, Meiler S, Poschenrieder F et al. 19. Recommendations of the Thoracic Imaging Section of the German Radiological Society for clinical application of chest imaging and structured CT reporting in the COVID-19 pandemic. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2020; Vogel-Claussen J, Ley- Zaporozhan J, Agarwal P et al. 20. Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China. Theranostics 2020; 10:6113-6121Li L, Yang L, Gui S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483442 21. Role of point-of-care ultrasound during the COVID-19 pandemic: our recommendations in the management of dialytic patients. Ultrasound J 2020; 12:30Vieira ALS, Pazeli Junior JM, Bastos MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488686

Immune response (16 articles)

1. Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19). Aging Dis 2020; 11:642-648Dong X, Wang M, Liu S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489708 2. Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol 2020:108487Roncati L, Ligabue G, Fabbiani L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479986 3. Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS- CoV-2) and Implications for Vaccines. Cureus 2020; 12:e8399Manners C, Larios Bautista E, Sidoti H, Lopez OJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499988 4. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression. Emerg Microbes Infect 2020; 9:1096-1101Shen L, Wang C, Zhao J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476607 5. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis 2020; Kang CK, Han GC, Kim M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492530 6. Reply to Carvalho. J Allergy Clin Immunol Pract 2020; Nyenhuis SM, Greiwe J, Zeiger JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474131 7. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro- inflammatory and anti-inflammatory cytokines. J Biol Regul Homeost Agents 2020; 34Ronconi G, Tete G, Kritas SK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476380 8. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). J. Biomed. Sci. 2020; 27:72Chang FY, Chen HC, Chen PJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498686 9. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD- 19 patient with diarrhea. J Med Virol 2020; Carnevale S, Beretta P, Morbini P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492199 10. Endothelial cell infection and endotheliitis in COVID-19. The Lancet 2020; 395:1417-1418Varga Z, Flammer AJ, Steiger P et al. 11. The immune system and COVID-19: Friend or foe? Life Sci 2020:117900Yazdanpanah F, Hamblin MR, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502542 12. COVID-19: Loss of bridging between innate and adaptive immunity? Med. Hypotheses 2020; 144:109861Rao VUS, Arakeri G, Subash A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32505066 13. Thromboinflammatory response in SARS-CoV-2 sepsis. Med. Leg. J. 2020:25817220926915Maiese A, Passaro G, Matteis A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490726 14. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; Ackermann M, Verleden SE, Kuehnel M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32437596 15. COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 2020; Teuwen LA, Geldhof V, Pasut A, Carmeliet P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32439870 16. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis 2020:101755Dhama K, Patel SK, Pathak M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479816

Management – misc. diseases (110 articles)

1. COVID 19: Surgery & the question of race. Am. J. Surg. 2020; Collier KT, Rothstein DH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498946 2. Expedited SARS-CoV-2 Screening of Donors and Recipients Supports Continued Solid Organ Transplant. Am J Transplant 2020; Lieberman JA, Mays JA, Wells C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476285 3. Orthopedic healthcare in the time of COVID-19: Experience of the orthopedic surgery department at Mustapha Bacha Hospital, Algeria. Ann Med Surg (Lond) 2020; 55:164-166Meraghni N, Benkaidali R, Derradji M, Kara Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483487 4. Improved safety of endoscopic vessel harvesting during the COVID-19 pandemic. Ann Thorac Surg 2020; Ali Hassan SM, Palacios CM, Ethier T, Bisleri G. http://www.ncbi.nlm.nih.gov/pubmed/? term=32504604 5. Principles for Managing Patients with Spinal Ailments in the Coronavirus Disease 2019 Era: What Do We Know So Far? An Evidence-Based, Narrative Review. Asian Spine J 2020; Viswanathan VK, Subramanian S, Rao AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493004 6. A brave new world: the new normal for general practice after the COVID-19 pandemic. BJGP Open 2020; Khan N, Jones D, Grice A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487520 7. Provision of Emergency Maxillofacial Service During the COVID-19 Pandemic : A Collaborative Five Centre UK Study. Br. J. Oral Maxillofac. Surg. 2020; Blackhall KK, Downie IP, Ramchandani P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482348 8. Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). Breast 2020; 52:110-115Gasparri ML, Gentilini OD, Lueftner D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502796 9. Management of primary skin cancer during a pandemic: Multidisciplinary recommendations. Cancer 2020; Baumann BC, MacArthur KM, Brewer JD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478867 10. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal. Cancer 2020; Huang SH, O'Sullivan B, Su J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478895 11. COVID-19 and heme oxygenase: novel insight into the disease and potential therapies. Cell Stress Chaperones 2020; Hooper PL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500379 12. Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button. Clin Pharmacol Ther 2020; Holstein SA, Vose JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484908 13. Impact of COVID-19 on Canadian medical oncologists and cancer care: Canadian Association of Medical Oncologists survey report. Curr. Oncol. 2020; 27:71-74Gill S, Hao D, Hirte H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489248 14. Influence of COVID-19 pandemic on hospitalizations at the tertiary dermatology department in south-west Poland. Dermatol Ther 2020; Bialynicki-Birula R, Siemasz I, Otlewska A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478949 15. Laser Safety Measures for The Treatment of Genital Warts in Hiv+ Patients During The Covid-19 Pandemic. Dermatol Ther 2020:e13750Cameli N, Mariano M, Latini A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495468 16. Recommendations for Diagnosis and Treatment of Onychomycosis During the COVID-19 Pandemic. Dermatol Ther 2020:e13709Lipner SR, Ricardo JW. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474984 17. Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment. Dermatol Ther 2020; Magnano M, Balestri R, Bardazzi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475056 18. Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic. Dermatol Ther 2020:e13722Melis D, Mugheddu C, Sanna S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475036 19. How Can I Take Care Of You? The Dermatologist Meets Patients' Needs During The Covid19 Pandemic. Dermatol Ther 2020; Radi G, Simonetti O, Diotallevi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478970 20. Recommendations for Treatment of Nail Psoriasis During the COVID-19 Pandemic. Dermatol Ther 2020:e13757Ricardo JW, Lipner SR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495952 21. Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID-19 pandemic: a single-center real-life experience. Dermatol Ther 2020:e13765Rossi M, Rovati C, Arisi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500660 22. Global Coronavirus Pandemic (SARS CoV-2): Past, Present, And Future Of Pediatric Dermatology. Dermatol Ther 2020:e13767Simonetti O, Diotallevi F, Campanati A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500648 23. Psoriatic Arthritis and COVID-19 Pandemic: Consequences in Medical Treatment? Dermatol Ther 2020:e13743Wollina U, Fioranelli M, Goldust M, Lotti T. http://www.ncbi.nlm.nih.gov/pubmed/? term=32478971 24. Management of diabetic persons with foot ulceration during COVID-19 health care emergency: effectiveness of a new triage pathway. Diabetes Res Clin Pract 2020:108245Marco M, Valentina I, Laura G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497745 25. The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons. Dis. Esophagus 2020; Kamarajah SK, Markar SR, Singh P, Griffiths EA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500134 26. The public health response to the COVID-19 pandemic for people with disabilities. Disabil Health J 2020:100943Boyle CA, Fox MH, Havercamp SM, Zubler J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32499132 27. Role of pharmacists in COVID-19 disease: a Jordanian perspective. Disaster Med Public Health Prep 2020:1-17Abdel Jalil MH, Alsous MM, Abu Hammour K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32498749 28. Psoriasis, biologic therapy, and the pandemic of the 21st century. Drugs Context 2020; 9Nogueira M, Vender R, Torres T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32477419 29. Effect of shelter-in-place on emergency department radiology volumes during the COVID-19 pandemic. Emerg Radiol 2020; Houshyar R, Tran-Harding K, Glavis-Bloom J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504280 30. [The effects of quarantine for SARS-CoV-2 on sleep: An online survey]. Encephale 2020; Hartley S, Colas des Francs C, Aussert F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475692 31. Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy? Endocrine 2020; Lombardi CP, D'Amore A, Grani G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32500518 32. Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2020; Herman P, Vincent C, Parietti Winkler C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482571 33. Thoracic surgeons' insights: Improving thoracic surgery outcomes during the Coronavirus Disease 2019 pandemic. Eur J Cardiothorac Surg 2020; Chen KN, Gao S, Liu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496537 34. 2020PMD, 30-years of Translational Mobility Medicine at the time of COVID-19 outbreak: Last-minute forewords from the editor. Eur. J. Transl. Myol. 2020; 30:8966Carraro U. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499903 35. Is it Possible to Safely Maintain a Regular Vascular Practice During the COVID-19 Pandemic? Eur. J. Vasc. Endovasc. Surg. 2020; Pini R, Faggioli G, Vacirca A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32499169 36. Learning from the past: did experience with previous epidemics help mitigate the impact of COVID- 19 among spine surgeons worldwide? Eur. Spine J. 2020; Weiner JA, Swiatek PR, Johnson DJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500177 37. Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS. Front. Immunol. 2020; 11:1059Mohn N, Pul R, Kleinschnitz C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32477373 38. Emergency ophthalmic surgeries during COVID-19-a Hong Kong perspective. Graefes Arch Clin Exp Ophthalmol 2020; Tang EWH, Wong DHT, Chan YYY, Li KKW. http://www.ncbi.nlm.nih.gov/pubmed/? term=32494874 39. COVID-19 and hand surgery. Hand Surg Rehabil 2020; Yasri S, Wiwanitkit V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474123 40. Clinical and surgical management of patients with head and neck cancer in a COVID-19 dedicated center in Italy. Head Neck 2020; Galli J, Settimi S, Tricarico L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32476204 41. Telemedicine for head and neck ambulatory visits during COVID-19: Evaluating usability and patient satisfaction. Head Neck 2020; Layfield E, Triantafillou V, Prasad A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476228 42. Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors. Immunotherapy 2020; Vici P, Pizzuti L, Krasniqi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489118 43. Tor Vergata University-Hospital in the Beginning of COVID-19-Era: Experience and Recommendation for Breast Cancer Patients. In Vivo 2020; 34:1661-1665Buonomo OC, Materazzo M, Pellicciaro M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503826 44. Breast Cancer Surgery During the COVID-19 Pandemic: An Observational Clinical Study of the Breast Surgery Clinic at Ospedale Policlinico San Martino - Genoa, Italy. In Vivo 2020; 34:1667- 1673Fregatti P, Gipponi M, Giacchino M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503827 45. Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process. In Vivo 2020; 34:1651-1659Vanni G, Materazzo M, Pellicciaro M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503825 46. The Effect of Coronavirus (COVID-19) on Breast Cancer Teamwork: A Multicentric Survey. In Vivo 2020; 34:1685-1694Vanni G, Materazzo M, Santori F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503830 47. Radiation Therapy During the COVID-19 Pandemic: Experience from Beijing, China. In Vivo 2020; 34:1675-1680Wang W, Liu X, Zhang F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503828 48. Severe Complicated Influenza Declined During the Prevention of COVID-19 in Taiwan. Infect Control Hosp Epidemiol 2020:1-8Yang CJ, Chen TC, Kuo SH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489160 49. The impact of COVID-19 pandemic in the colorectal cancer prevention. Int. J. Colorectal Dis. 2020; Del Vecchio Blanco G, Calabrese E, Biancone L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500432 50. Eating and exercise behaviors in eating disorders and the general population during the COVID-19 pandemic in Australia: Initial results from the COLLATE project. Int. J. Eat. Disord. 2020; Phillipou A, Meyer D, Neill E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476163 51. The impact of the COVID-19 pandemic on eating disorder risk and symptoms. Int. J. Eat. Disord. 2020; Rodgers RF, Lombardo C, Cerolini S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476175 52. COVID-19 Outbreak Perception in Italian Dentists. Int J Environ Res Public Health 2020; 17De Stefani A, Bruno G, Mutinelli S, Gracco A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485959 53. Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020. Int J Infect Dis 2020; Itaya T, Furuse Y, Jindai K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492532 54. Perspectives on how to navigate cancer surgery in the breast, head and neck, skin, and soft tissue tumor in limited-resource countries during COVID-19 pandemic. Int J Surg 2020; Anwar SL, Harahap WA, Aryandono T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497751 55. Critical adjustments in a department of orthopaedics through the COVID-19 pandemic. Int. Orthop. 2020; Luengo-Alonso G, Perez-Tabernero FG, Tovar-Bazaga M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474718 56. Impact of the COronaVIrus Disease 2019 lockdown on hand and upper limb emergencies: experience of a referred university trauma hand centre in Paris, France centre in Paris, France. Int. Orthop. 2020; Pichard R, Kopel L, Lejeune Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488564 57. Challenges and countermeasures in the prevention of nosocomial infections of SARS-CoV-2 before resumption of work: implications for the dermatology department. J Am Acad Dermatol 2020; Zhang Y, Wen J, Chen C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497702 58. Appropriate arrangement of cancer treatment after COVID-19 epidemic peaks in China. J. Cancer Res. Clin. Oncol. 2020; Mo H, Liu B, Ma F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474751 59. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease. J. Clin. Anesth. 2020; 66:109926Taboada M, Caruezo V, Naveira A, Atanassoff PG. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474331 60. Impact of COVID-19 on Urology Practice: A Global Perspective and Snapshot Analysis. J Clin Med 2020; 9Gravas S, Bolton D, Gomez R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503305 61. The Aftermath of COVID-19 in Dermatology Practice: What's next? J Cosmet Dermatol 2020; Ng JN, Cembrano KAG, Wanitphakdeedecha R, Manuskiatti W. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502318 62. Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto. J. Cutan. Med. Surg. 2020:1203475420930226Georgakopoulos JR, Yeung J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32475151 63. Challenges faced by patients with morphea in the era of SARS-CoV-2. J Dermatolog Treat 2020:1- 6Shahidi Dadras M, Namazi N, Nikvar M, Abdollahimajd F. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502370 64. Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice. J Eur Acad Dermatol Venereol 2020; Sacchelli L, Viviani F, Orioni G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32491214 65. Development and Validation of a Clinical Risk Score for Intensive Care Resource Utilization After Colon Cancer Surgery: a Practical Guide to the Selection of Patients During COVID-19. J Gastrointest Surg 2020; Garfinkle R, Abou-Khalil M, Salama E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495141 66. Responsible Return to Essential and Non-Essential Surgery During the COVID-19 Pandemic. J Gastrointest Surg 2020; Poulose BK, Phieffer LS, Mayerson J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32500416 67. Novel corona virus disease (COVID-19) awareness among the dental interns, dental auxiliaries and dental specialists in Saudi Arabia: A nationwide study. J Infect Public Health 2020; Quadri MFA, Jafer MA, Alqahtani AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475807 68. The rediscovery of hydroxychloroquine in allergic diseases in the COVID-19 era. J. Investig. Allergol. Clin. Immunol. 2020:0Bonzano L, Cassone G, Tarallo L, Pellacani G. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474406 69. Letter to the Editor: Robot-Assisted and Minimally Invasive Pediatric Surgery and Urology During the COVID-19 Pandemic: A Short Literature Review. J. Laparoendosc. Adv. Surg. Tech. A 2020; Esposito C, Masieri L, Castagnetti M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498612 70. National outreach of telepalliative medicine volunteers for a New York City safety net system COVID-19 pandemic response. J Pain Symptom Manage 2020; Israilov S, Krouss M, Zaurova M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479861 71. COVID - A Caring Reflection. J Pastoral Care Counsel 2020; 74:141Sylvester AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496947 72. Breast reconstruction and the COVID-19 pandemic: A viewpoint. J. Plast. Reconstr. Aesthet. Surg. 2020; Pace BD, Benson JR, Malata CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487361 73. How the COVID-19 pandemic changed the Plastic Surgery activity in a regional referral center in Northern Italy. J. Plast. Reconstr. Aesthet. Surg. 2020; Pignatti M, Pinto V, Miralles MEL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499187 74. Management of patients with ovarian cancer in the COVID-19 era. J. Surg. Oncol. 2020; Bogani G, Casarin J, Pinelli C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476155 75. Flattening the curve in oncologic surgery: Impact of Covid-19 on surgery at tertiary care cancer center. J. Surg. Oncol. 2020; Chang EI, Liu JJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488866 76. Strategy for treating vascular emergencies during the COVID-19 pandemic in China. J. Vasc. Surg. 2020; Wang J, Kuang M, Chen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497746 77. Infection control of operating room and anesthesia for cesarean section during pandemic Coronavirus disease-19 (COVID-19) outbreak in Daegu, the republic of Korea - 8 cases report. Korean J Anesthesiol 2020; Oh J, Kim E, Kim H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32498490 78. COVID-19: Preliminary Clinical Guidelines for Ophthalmology Practices. Med Hypothesis Discov Innov Ophthalmol 2020; 9:149-158Gharebaghi R, Desuatels J, Moshirfar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490022 79. COVID-19 and Ophthalmology: A New Chapter in an Old Story. Med Hypothesis Discov Innov Ophthalmol 2020; 9:71-73Reviglio VE, Osaba M, Reviglio V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32490013 80. Maximizing the academic nursing model in the era of COVID-19 and beyond. Nurs. Outlook 2020; Bettencourt AP, Vance AJ, Jun J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475612 81. Management of neovascular age-related macular degeneration during the COVID-19 pandemia. Ophthalmol Retina 2020; Corradetti G, Corvi F, Nguyen TV, Sadda SR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480013 82. Time for a Paradigm Shift in Head and Neck Cancer Management During the COVID-19 Pandemic. Otolaryngol Head Neck Surg 2020:194599820931789Han AY, Miller JE, Long JL, St John MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484380 83. Rhinologic Practice Special Considerations During COVID-19: Visit Planning, Personal Protective Equipment, Testing, and Environmental Controls. Otolaryngol Head Neck Surg 2020:194599820933169Howard BE, Lal D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484728 84. Otolaryngology in the Time of Corona: Assessing Operative Impact and Risk During the COVID-19 Crisis. Otolaryngol Head Neck Surg 2020:194599820930214Kuhar HN, Heilingoetter A, Bergman M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482131 85. Back to the Future: Principles on Resuming Outpatient Services in the COVID-19 Era. Otolaryngol Head Neck Surg 2020:194599820933597Valika TS, Billings KR. http://www.ncbi.nlm.nih.gov/pubmed/? term=32482142 86. A Guiding Principles Checklist for Otolaryngologic Surgery in the COVID-19 Era. Otolaryngol Head Neck Surg 2020:194599820933253Valika TS, Maurrasse SE, Thompson DM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482124 87. Care of Patients With a Laryngectomy During the COVID-19 Pandemic. Otolaryngol Head Neck Surg 2020:194599820933185Yeung DCM, Lai R, Wong EWY, Chan JYK. http://www.ncbi.nlm.nih.gov/pubmed/? term=32482154 88. Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks. Pharmacol. Res. 2020; 158:104917Boccanegra B, Verhaart IEC, Cappellari O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485610 89. Eating disorders in the age of COVID-19. Psychiatry Res 2020; 290:113122Shah M, Sachdeva M, Johnston H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480115 90. Chinese Society of Interventional Radiology Expert Consensus on the prevention and control of COVID-19 in interventional radiology procedures (first edition). Quant Imaging Med Surg 2020; 10:1045-1057Zhu Y, He Y, Wang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489928 91. Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups. Radiat Oncol 2020; 15:140Vordermark D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493443 92. Radiological management of COVID-19: structure your diagnostic path to guarantee a safe path. Radiol Med 2020; Stramare R, Carretta G, Capizzi A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32500510 93. Managing a radiotherapy center safely and efficiently using risk-adaptive strategies during coronavirus disease pandemic: Experience from national cancer center of china. Radiother Oncol 2020; Bi N, Yi J, Dai J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479778 94. Evolution of clinical radiotherapy physics practice under COVID-19 constraints. Radiother Oncol 2020; Khan R, Darafsheh A, Goharian M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474126 95. Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic. Radiother Oncol 2020; Mendez LC, Raziee H, Davidson M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474128 96. Mitigating the Impact of COVID-19 on Oncology: Clinical and Operational Lessons from a Prospective Radiation Oncology Cohort Tested for COVID-19. Radiother Oncol 2020; Ning MS, Frances McAleer M, Jeter MD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474129 97. Spanish risk management framework across 17 radiation oncology centers during COVID-19 pandemic. Radiother Oncol 2020; Suarez V, Moreno-Olmedo E, Perez M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479777 98. Community pharmacists' exposure to COVID-19. Res Social Adm Pharm 2020; Cabas P, Di Bella S, Giuffre M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499159 99. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies. Res Social Adm Pharm 2020; Romano S, Galante H, Figueira D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482587 100. Impact of the Covid-19 pandemic and lung transplantation program in France. Respir Med Res 2020; 78:100758Picard C, Le Pavec J, Tissot A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474398 101. Implications of COVID-19 in pediatric rheumatology. Rheumatol. Int. 2020; Batu ED, Ozen S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500409 102. Ancillary considerations for endodontic emergency treatment of Covid-19 positive patients. Spec. Care Dentist. 2020; Umer F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501576 103. Providing nutritional care to cancer patients during the COVID-19 pandemic: an Italian perspective. Support. Care Cancer 2020; Lobascio F, Caccialanza R, Monaco T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495030 104. [Surgery during the SARS-CoV-2 pandemic : Recommendations on operative procedures]. Unfallchirurg 2020; Mahlke L, Flohe S, Matthes G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32488319 105. Resuming elective surgery in the time of COVID-19: a safe and comprehensive strategy. Updates Surg. 2020; Al-Omar K, Bakkar S, Khasawneh L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495280 106. Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center. Updates Surg. 2020; Berardi G, Colasanti M, Levi Sandri GB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500431 107. Concerns in redirecting uro-oncologic patients during COVID-19 pandemic. Urology 2020; Campodonico F, Ennas M, Domenico AD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504678 108. Impact of COVID-19 outbreak on acute low back pain. World Neurosurg 2020; Borsa S, Pluderi M, Carrabba G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479910 109. Scoring system to triage patients for spine surgery in the setting of limited resources: Application to the COVID-19 pandemic and beyond. World Neurosurg 2020; Sciubba DM, Ehresman J, Pennington Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479913 110. Nasoseptal Flap Necrosis After Endoscopic Skull Base Surgery in the Setting of SARS-CoV- 2/COVID-19. World Neurosurg 2020; Talmor G, Grube JG, Eloy JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479908

Management (30 articles)

1. Using the prone position could help to combat the development of fast hypoxia in some patients with COVID-19. Acta Paediatr 2020; Lindahl SGE. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484966 2. Should We Monitor Pulsus Paradoxus via Pulse Oximetry in COVID-19 Patients with Acute Respiratory Failure? Am J Respir Crit Care Med 2020; Michard F, Shelley K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492351 3. Application of the PDCA cycle for standardized nursing management in a COVID-19 intensive care unit. Ann Palliat Med 2020; 9:1198-1205Chen Y, Zheng J, Wu D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498535 4. Swapping drills for dressings: redeployment of dentists to community nursing. Br. J. Community Nurs. 2020; 25:266-270Johnston L, Archer N, Martin K. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496858 5. Prone positioning in conscious patients on medical wards: A review of the evidence and its relevance to patients with COVID-19 infection. Clin Med (Lond) 2020; Chad T, Sampson C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503800 6. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 2020; Soy M, Keser G, Atagunduz P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474885 7. In-hospital airway management of COVID-19 patients. Crit Care 2020; 24:292Sullivan EH, Gibson LE, Berra L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503600 8. Towards individualized and optimalized positioning of non-ventilated COVID-19 patients: Putting the affected parts of the lung(s) on top? Diabetes Metab. 2020; Froelich S, Mandonnet E, Julla JB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473964 9. Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease. Gastroenterology 2020; Lukin DJ, Kumar A, Hajifathalian K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479824 10. [The Key Role of Taiwanese Nurses in Combating COVID-19 Pandemic]. Hu Li Za Zhi 2020; 67:84- 89Chen SF, Huang LH, Chen CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495333 11. [Nursing Experience of Caring for a Patient With COVID-19 During Isolation]. Hu Li Za Zhi 2020; 67:111-119Hsu TC, Wu CC, Lai PY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495337 12. Novel Coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries. Hum Vaccin Immunother 2020:1-3Anjum FR, Anam S, Rahman SU. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501130 13. The armed forces medical services response to COVID-19. Indian J. Public Health 2020; 64:S94- s95Banerji A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496233 14. Health systems preparedness during COVID-19 pandemic: China and India. Indian J. Public Health 2020; 64:S96-s98Baru RV. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496234 15. COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics. Indian J. Public Health 2020; 64:S221-s224Mishra V, Burma AD, Das SK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496259 16. Insouciance and inexperience: A deadly combination when dealing with COVID-19. Int. J. Health Plann. Manage. 2020; Paton C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490556 17. NANDA-I, NOC, and NIC Linkages to SARS-Cov-2 (Covid-19): Part 1. Community Response. Int J Nurs Knowl 2020; Moorhead S, Macieira TGR, Lopez KD et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497413 18. Turning a surgical unit into a COVID-19 facility: governance counts. Correspondence. Int J Surg 2020; Sfez M, Derichard A, Cittanova-Pansard ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502703 19. Successful use of methylprednisolone for treating severe COVID-19. J Allergy Clin Immunol 2020; Liu J, Zheng X, Huang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479759 20. Perianesthetic concerns for the non-COVID-19 patients requiring surgery during the COVID-19 pandemic outbreak: An observational study. J. Clin. Anesth. 2020; 66:109923Boccara G, Cassagnol D, Bargues L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480207 21. COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome. J Infect 2020; Hu J, Zhang X, Zhang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474032 22. Co-infections among patients with COVID-19: The need for combination therapy with non-anti- SARS-CoV-2 agents? J Microbiol Immunol Infect 2020; Lai CC, Wang CY, Hsueh PR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482366 23. A Hidden Key to COVID-19 Management in Korea: Public Health Doctors. J Prev Med Public Health 2020; 53:175-177Choi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498141 24. The association between treatment with heparin and survival in patients with Covid-19. J. Thromb. Thrombolysis 2020; Ayerbe L, Risco C, Ayis S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476080 25. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Espanola de Ginecologia y Obstetricia and Sociedad Espanola de Trombosis y Hemostasia. Maturitas 2020; 137:57-62Ramirez I, De la Viuda E, Baquedano L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498938 26. Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic. Res Social Adm Pharm 2020; Elbeddini A, Prabaharan T, Almasalkhi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499161 27. A 55-year-old COVID-19-positive man managed with self-regulation of high-flow oxygen by high- velocity nasal insufflation therapy. Respirol Case Rep 2020; 8:e00591Ciment AJ, Ciment LM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489666 28. Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19. Reumatol. Clin. 2020; Munoz-Jimenez A, Rubio-Romero E, Marenco de la Fuente JL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482538 29. Addressing a National Crisis: The Spine Hospital and Department's Response to the COVID-19 Pandemic in New York City. Spine J 2020; Lombardi JM, Bottiglieri T, Desai N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492529 30. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA). Vasa 2020:1-5Linnemann B, Bauersachs R, Grebe M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501145

Mental – public health (54 articles)

1. Private metropolitan telepsychiatry in Australia during Covid-19: current practice and future developments. Australas Psychiatry 2020:1039856220930675Looi JC, Pring W. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484737 2. Ethnic Disparities in Hospitalisation for COVID-19 in England: The Role of Socioeconomic Factors, Mental Health, and Inflammatory and Pro-inflammatory Factors in a Community-based Cohort Study. Brain Behav Immun 2020; Lassale C, Gaye B, Hamer M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497776 3. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun 2020; Vindegaard N, Eriksen Benros M. http://www.ncbi.nlm.nih.gov/pubmed/? term=32485289 4. Psychological and Behavioral Response to the Coronavirus (COVID-19) Pandemic. Cureus 2020; 12:e7923Balkhi F, Nasir A, Zehra A, Riaz R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499970 5. COVID-19 Information Seeking on Digital Media and Preventive Behaviors: The Mediation Role of Worry. Cyberpsychol Behav Soc Netw 2020; Liu PL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498549 6. COVID-19 Crisis: Early Observations on a Pandemic's Psychiatric Problems. Deutsche Medizinische Wochenschrift 2020; 145:675-681Fatke B, Hölzle P, Frank A, Förstl H. 7. The public health response to the COVID-19 pandemic for people with disabilities. Disabil Health J 2020:100943Boyle CA, Fox MH, Havercamp SM, Zubler J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32499132 8. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis. Disabil Health J 2020:100942Turk MA, Landes SD, Formica MK, Goss KD. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473875 9. The Mental Health Consequences of COVID-19 pandemic in Dentistry. Disaster Med Public Health Prep 2020:1-13Vergara-Buenaventura A, Chavez-Tunon M, Castro-Ruiz C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498741 10. [Mental health care in French correctional facilities during the Covid-19 pandemic]. Encephale 2020; Fovet T, Lancelevee C, Eck M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475693 11. [The effects of quarantine for SARS-CoV-2 on sleep: An online survey]. Encephale 2020; Hartley S, Colas des Francs C, Aussert F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475692 12. The social psychological impact of the COVID-19 epidemic on medical staff in China: a cross- sectional study. Eur. Psychiatry 2020:1-22Dong ZQ, Ma J, Hao YN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476633 13. Mental health among otolaryngology resident and attending physicians during the COVID-19 pandemic: National study. Head Neck 2020; Civantos AM, Byrnes Y, Chang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496637 14. Rural Health, Behavioral Health, And More. Health Aff (Millwood) 2020; 39:919-920Weil AR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479231 15. [Exploring the Stress, Psychological Distress, and Stress-relief Strategies of Taiwan Nursing Staffs Facing the Global Outbreak of COVID-19]. Hu Li Za Zhi 2020; 67:64-74Feng MC, Wu HC, Lin HT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495331 16. Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process. In Vivo 2020; 34:1651-1659Vanni G, Materazzo M, Pellicciaro M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503825 17. Related Health Factors of Psychological Distress During the COVID-19 Pandemic in Spain. Int J Environ Res Public Health 2020; 17Gomez-Salgado J, Andres-Villas M, Dominguez-Salas S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498401 18. Coping with COVID-19: Exposure to COVID-19 and Negative Impact on Livelihood Predict Elevated Mental Health Problems in Chinese Adults. Int J Environ Res Public Health 2020; 17Guo J, Feng XL, Wang XH, van IMH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485859 19. Distress and Resilience in the Days of COVID-19: Comparing Two Ethnicities. Int J Environ Res Public Health 2020; 17Kimhi S, Eshel Y, Marciano H, Adini B. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503205 20. The Impact of COVID-19 on Physical Activity Behavior and Well-Being of Canadians. Int J Environ Res Public Health 2020; 17Lesser IA, Nienhuis CP. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486380 21. The Psychological Impacts of a COVID-19 Outbreak on College Students in China: A Longitudinal Study. Int J Environ Res Public Health 2020; 17Li HY, Cao H, Leung DYP, Mak YW. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498267 22. COVID-19 Emergence and Social and Health Determinants in Colorado: A Rapid Spatial Analysis. Int J Environ Res Public Health 2020; 17Ramirez IJ, Lee J. http://www.ncbi.nlm.nih.gov/pubmed/? term=32485854 23. Psychological impact of COVID-19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period. Int J Gynaecol Obstet 2020; Zanardo V, Manghina V, Giliberti L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474910 24. Social consequences of COVID-19 in a low resource setting in Sierra Leone, West Africa. Int J Infect Dis 2020; Buonsenso D, Cinicola B, Raffaelli F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497794 25. Emergency mental health legislation in response to the Covid-19 (Coronavirus) pandemic in Ireland: Urgency, necessity and proportionality. Int. J. Law Psychiatry 2020; 70:101564Kelly BD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482306 26. The psychosocial effects of being quarantined following exposure to COVID-19: A qualitative study of Lebanese health care workers. Int J Soc Psychiatry 2020:20764020932202Fawaz M, Samaha A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489149 27. COVID-19 quarantine: Post-traumatic stress symptomatology among Lebanese citizens. Int J Soc Psychiatry 2020:20764020932207Fawaz M, Samaha A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489136 28. Mental health of older adults during the COVID-19 pandemic: lessons from history to guide our future. Int. Psychogeriatr. 2020:1-4Chong TWH, Curran E, Ames D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489166 29. Mental Health and the COVID19 Pandemic. Ir. J. Psychol. Med. 2020:1-7Gavin B, Lyne J, McNicholas F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475368 30. Could COVID-19 improve psychiatric awareness at the heart of the Middle East? - A personal reflection on Bahrain's response. Ir. J. Psychol. Med. 2020:1-8Maher Negm H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484123 31. Adolescents' Motivations to Engage in Social Distancing During the COVID-19 Pandemic: Associations With Mental and Social Health. J. Adolesc. Health 2020; Oosterhoff B, Palmer CA, Wilson J, Shook N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487491 32. COVID-19: Implications for the Support of People with Social Care Needs in England. J Aging Soc Policy 2020:1-8Comas-Herrera A, Fernandez JL, Hancock R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497462 33. The Unique Challenges Faced by Assisted Living Communities to Meet Federal Guidelines for COVID-19. J Aging Soc Policy 2020:1-9Dobbs D, Peterson L, Hyer K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496899 34. Rapid Systematic Review: The Impact of Social Isolation and Loneliness on the Mental Health of Children and Adolescents in the Context of COVID-19. J. Am. Acad. Child Adolesc. Psychiatry 2020; Loades ME, Chatburn E, Higson-Sweeney N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504808 35. Health anxiety, cyberchondria, and coping in the current COVID-19 pandemic: Which factors are related to coronavirus anxiety? J. Anxiety Disord. 2020; 73:102239Jungmann SM, Witthoft M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502806 36. Managing uncertainty during a global pandemic: An international business perspective. J Bus Res 2020; 116:188-192Sharma P, Leung TY, Kingshott RPJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501304 37. Social-economic impact of COVID-19 pandemic on aesthetic centers in Greece. J Cosmet Dermatol 2020; Biskanaki F, Rallis E, Andreou E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475018 38. The potential impact of vulnerability and coping capacity on the pandemic control of COVID-19. J Infect 2020; Wong MC, Teoh JY, Huang J, Wong SH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474040 39. A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19. J Med Virol 2020; Zhang Z, Wang S, Tu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501538 40. A review of pathophysiology and neuropsychiatric manifestations of COVID-19. J. Neurol. 2020; Jasti M, Nalleballe K, Dandu V, Onteddu S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494854 41. Syndemic frameworks to understand the effects of COVID-19 on commercial driver stress, health, and safety. J Transp Health 2020; 18:100877Lemke MK, Apostolopoulos Y, Sonmez S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501420 42. The impact of the Covid-19 pandemic on domestic violence: The dark side of home isolation during quarantine. Med. Leg. J. 2020:25817220930553Sacco MA, Caputo F, Ricci P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501175 43. Psychological support and psychotherapy via digital devices in Covid-19 emergency time: Some critical issues. Med. Leg. J. 2020:25817220926942Tullio V, Perrone G, Bilotta C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490713 44. What has Covid-19 taken from us and brought instead? Oral Dis 2020; Buduneli N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474987 45. Dysfunctional personality features, non-scientifically supported causal beliefs, and emotional problems during the first month of the COVID-19 pandemic in Italy. Pers. Individ. Dif. 2020; 165:110139Somma A, Gialdi G, Krueger RF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501318 46. Schizophrenia and COVID-19 delirium. Psychiatry Res 2020; 290:113137Palomar-Ciria N, Blanco Del Valle P, Hernandez-Las Heras MA, Martinez-Gallardo R. http://www.ncbi.nlm.nih.gov/pubmed/? term=32485483 47. The impacts of vulnerability, perceived risk, and fear on preventive behaviours against COVID-19. Psychol Health Med 2020:1-9Yildirim M, Gecer E, Akgul O. http://www.ncbi.nlm.nih.gov/pubmed/? term=32490689 48. On the clinical psychologist's role in the time of COVID-19, with particular reference to experience gained in pediatric oncology. Psychooncology 2020; Clerici CA, Massimino M, Ferrari A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501640 49. COVID-19 and Intimate Partner Violence: A Call to Action. R I Med J (2013) 2020; 103:57-59Zero O, Geary M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32481784 50. The psychological impact of COVID-19 pandemic on physicians in Saudi Arabia: A cross-sectional study. Saudi J. Gastroenterol. 2020; Al Sulais E, Mosli M, AlAmeel T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496223 51. The impact of COVID-19 on individuals living with serious mental illness. Schizophr Res 2020; Hamada K, Fan X. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473931 52. The evaluation of sleep disturbances for Chinese frontline medical workers under the outbreak of COVID-19. Sleep Med. 2020; 72:1-4Qi J, Xu J, Li BZ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502844 53. Perceived stress and sleep quality among the non-diseased general public in China during the 2019 coronavirus disease: a moderated mediation model. Sleep Med. 2020; Zhao X, Lan M, Li H, Yang J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482485 54. [Consideration on improving public health emergency management ability of current medical health system]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41:E072Cao GW, Zhang BX, Chen XP. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498493

Meta-analyses - systematic reviews (8 articles)

1. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis. Aging Dis 2020; 11:668-678Liu H, Chen S, Liu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489711 2. Systematic Review and Meta-Analysis on the Value of Chest CT in the Diagnosis of Coronavirus Disease (COVID-19): Sol Scientiae, Illustra Nos. AJR Am J Roentgenol 2020:1-9Adams HJA, Kwee TC, Yakar D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478562 3. Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis. J Infect 2020; Liu M, Gao Y, Shi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474047 4. The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis. J Infect 2020; Liu M, Gao Y, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502509 5. Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis. J Infect 2020; Pirola CJ, Sookoian S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474043 6. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care 2020; 8:36Huang I, Pranata R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483488 7. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis. J Med Virol 2020; Aikawa T, Takagi H, Ishikawa K, Kuno T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484975 8. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev Med Virol 2020:e2112Pormohammad A, Ghorbani S, Khatami A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502331 Mortality (10 articles)

1. COVID-19, economic impact and child mortality: A global concern. Clin. Nutr. 2020; Kabir M, Saqib MAN, Zaid M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499056 2. A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm). IDCases 2020; 21:e00829Chhetri S, Khamis F, Pandak N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483525 3. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int. J. Legal Med. 2020; Edler C, Schroder AS, Aepfelbacher M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500199 4. Gross and histopathological pulmonary findings in a COVID-19 associated death during self- isolation. Int. J. Legal Med. 2020; Suess C, Hausmann R. http://www.ncbi.nlm.nih.gov/pubmed/? term=32504146 5. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J. Clin. Endocrinol. Metab. 2020; Bello-Chavolla OY, Bahena-Lopez JP, Antonio-Villa NE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474598 6. Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury. J Clin Med 2020; 9Lim JH, Park SH, Jeon Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503180 7. Estimating the Risk of COVID-19 Death During the Course of the Outbreak in Korea, February-May 2020. J Clin Med 2020; 9Shim E, Mizumoto K, Choi W, Chowell G. http://www.ncbi.nlm.nih.gov/pubmed/? term=32485871 8. Dead body management amidst global pandemic of Covid-19. Med. Leg. J. 2020:25817220926930Vidua RK, Duskova I, Bhargava DC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501134 9. Role of a habitat's air humidity in Covid-19 mortality. Sci Total Environ 2020; 736:138763Biktasheva IV. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492610 10. [Thoughts and suggestions on analysis of death cases report during COVID-19 epidemic]. Zhongguo Zhong Yao Za Zhi 2020; 45:1531-1535Li B, Yan YM, Li ZY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489031

On-line – IT – Apps (31 articles)

1. Private metropolitan telepsychiatry in Australia during Covid-19: current practice and future developments. Australas Psychiatry 2020:1039856220930675Looi JC, Pring W. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484737 2. Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Braz. J. Infect. Dis. 2020; Hoagland B, Torres TS, Bezerra DRB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504552 3. Feasibility and Preliminary Results of Effectiveness of Social Media-based Intervention on the Psychological Well-being of Suspected COVID-19 Cases during Quarantine. Can. J. Psychiatry. 2020:706743720932041Zhou L, Xie RH, Yang X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32483978 4. Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India. Clin Rheumatol 2020; Shenoy P, Ahmed S, Paul A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474883 5. COVID-19 and applications of smartphone technology in the current pandemic. Diabetes Metab Syndr 2020; 14:733-737Iyengar K, Upadhyaya GK, Vaishya R, Jain V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497963 6. Coronavirus Disease (COVID-19): A Machine Learning Bibliometric Analysis. In Vivo 2020; 34:1613- 1617F DEF, Polimeni A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503819 7. An overview of mobile applications (apps) to support the coronavirus disease-2019 response in India. Indian J Med Res 2020; Bassi A, Arfin S, John O, Jha V. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474557 8. Factors affecting the adoption of telemedicine during COVID-19. Indian J. Public Health 2020; 64:S234-s236Mishra V. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496263 9. A modified deep convolutional neural network for detecting COVID-19 and pneumonia from chest X- ray images based on the concatenation of Xception and ResNet50V2. Inform Med Unlocked 2020; 19:100360Rahimzadeh M, Attar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501424 10. A Visual Approach for the SARS (Severe Acute Respiratory Syndrome) Outbreak Data Analysis. Int J Environ Res Public Health 2020; 17Hua J, Wang G, Huang M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503333 11. Robotics Utilization for Healthcare Digitization in Global COVID-19 Management. Int J Environ Res Public Health 2020; 17Khan ZH, Siddique A, Lee CW. http://www.ncbi.nlm.nih.gov/pubmed/? term=32481547 12. Management strategies and role of telemedicine in a Surgery Unit during COVID-19 outbreak. Int J Surg 2020; Palomba G, Dinuzzi VP, Aprea G, De Palma GD. http://www.ncbi.nlm.nih.gov/pubmed/? term=32479914 13. Effectively Engaging Geriatric Patients via Teledermatology. J Am Acad Dermatol 2020; Simpson CL, Kovarik CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497703 14. Rapid Deployment of Inpatient Telemedicine In Response to COVID-19 Across Three Health Systems. J Am Med Inform Assoc 2020; Vilendrer S, Patel B, Chadwick W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495830 15. Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients. J Clin Med 2020; 9Cheng FY, Joshi H, Tandon P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492874 16. COVID-19 Awakens a New Focus on Surge Capacity Blood Glucose Testing and the Critical Role of Telehealth in Self-Management. J. Diabetes Sci. Technol. 2020:1932296820930035Fantz CR, Rivers M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486964 17. COVID-19 and Diabetes: Could Diabetes Technology Research Help Pave the Way for Remote Healthcare? J. Diabetes Sci. Technol. 2020:1932296820929714Fuchs J, Hovorka R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475169 18. COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil. J. Diabetes Sci. Technol. 2020:1932296820930033Teles M, Sacchetta T, Matsumoto Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482098 19. Learning From COVID-19 and Looking to Technology Ahead. J. Diabetes Sci. Technol. 2020:1932296820930280Toft AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482092 20. COVID-19-Related Information Sources and the Relationship With Confidence in People Coping with COVID-19: Facebook Survey Study in Taiwan. J Med Internet Res 2020; 22:e20021Wang PW, Lu WH, Ko NY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490839 21. National outreach of telepalliative medicine volunteers for a New York City safety net system COVID-19 pandemic response. J Pain Symptom Manage 2020; Israilov S, Krouss M, Zaurova M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479861 22. Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine. J Pharm Policy Pract 2020; 13:23Elbeddini A, Yeats A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501410 23. Impact of Rumors and Misinformation on COVID-19 in Social Media. J Prev Med Public Health 2020; 53:171-174Tasnim S, Hossain MM, Mazumder H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498140 24. Telemedicine during Covid-19 pandemic: Advantage or critical issue? Med. Leg. J. 2020:25817220926926Perrone G, Zerbo S, Bilotta C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32490720 25. Family doctor-centered care: Continuous monitoring of COVID-19 patients - New software module. MMW-Fortschritte der Medizin 2020; 162:35fst. 26. Predicting COVID-19 Incidence Using Anosmia and Other COVID-19 Symptomatology: Preliminary Analysis Using Google and Twitter. Otolaryngol Head Neck Surg 2020:194599820932128Panuganti BA, Jafari A, MacDonald B, DeConde AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484425 27. Telemedicine and the Interdisciplinary Clinic Model: During the COVID-19 Pandemic and Beyond. Otolaryngol Head Neck Surg 2020:194599820932167Zughni LA, Gillespie AI, Hatcher JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484731 28. Usefulness of a Telemedicine Tool TELEA in the Management of the COVID-19 Pandemic. Telemed J E Health 2020; Rabunal R, Suarez-Gil R, Golpe R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501747 29. Tele-oncology in the COVID-19 Era: The Way Forward? Trends Cancer 2020; Shirke MM, Shaikh SA, Harky A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487487 30. A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial. Trials 2020; 21:469Vandormael A, Adam M, Greuel M, Barnighausen T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493460 31. Virtual Spine: A novel, international teleconferencing program developed to increase the accessibility of spine education during the COVID-19 pandemic. World Neurosurg 2020; Rasouli JJ, Shin JH, Than KD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474104

Other – Miscellaneous (34 articles)

1. [Medical Professionalism and the Social Contract: Reflections on the COVID-19 Pandemic]. Acta Med Port 2020; 33:362-364Ferreira MA, Carvalho Filho MA, Franco GS, Franco RS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504510 2. Home delivery of medication during Coronavirus disease 2019, Cape Town, South Africa: Short report. Afr J Prim Health Care Fam Med 2020; 12:e1-e4Brey Z, Mash R, Goliath C, Roman D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501022 3. COVID-19, Prison Visits, and the Value of a Cup of Coffee. Ann Intern Med 2020; Doyle TJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479164 4. 21-Day Lockdown in India Dramatically Reduced Air Pollution Indices in Lucknow and New Delhi, India. Bull. Environ. Contam. Toxicol. 2020; Srivastava S, Kumar A, Bauddh K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495123 5. The impact of COVID-19 pandemic upon stability and sequential irregularity of equity and cryptocurrency markets. Chaos Solitons Fractals 2020; 138:109936Lahmiri S, Bekiros S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501379 6. Tuberculosis Healthcare Workers: There Goes My Hero. Clin Infect Dis 2020; Griffith DE, Cegielski JP. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502233 7. Historical evidence for economic effects of COVID-19. Eur J Health Econ 2020; Ceylan RF, Ozkan B, Mulazimogullari E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500243 8. Community Health Workers And COVID-19. Health Aff (Millwood) 2020; 39:1097Hansmann KJ, Kind AJH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479233 9. Community Health Workers: The Authors Reply. Health Aff (Millwood) 2020; 39:1097Kangovi S, Asch DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479214 10. Risk-Informed Decision Making: More Critical Today Than Ever Before. Health Secur 2020; Watson C, Mullen L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497443 11. Knowledge, attitude, and practices related to COVID-19 pandemic among social media users in J&K, India. Indian J. Public Health 2020; 64:S205-s210Dkhar SA, Quansar R, Saleem SM, Khan SMS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496256 12. Concerns of Frontline Doctors in India during COVID-19: A Cross-Sectional Survey. Indian J. Public Health 2020; 64:S237-s239Singh H, Sharma S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496264 13. "Not Wars, Water pumps" - From emotive to rational language in managing the Covid-19 pandemic. Int J Clin Pract 2020; Stedman M, Davies M, Heald A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502319 14. Crafting Jobs for Occupational Satisfaction and Innovation among Manufacturing Workers Facing the COVID-19 Crisis. Int J Environ Res Public Health 2020; 17Ren T, Cao L, Chin T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503169 15. COVID-19 and fiscal space for health system in Pakistan: It is time for a policy decision. Int. J. Health Plann. Manage. 2020; Shaikh BT, Ali N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476158 16. Employee adjustment and well-being in the era of COVID-19: Implications for human resource management. J Bus Res 2020; 116:183-187Carnevale JB, Hatak I. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501303 17. Masters of disasters? Challenges and opportunities for SMEs in times of crisis. J Bus Res 2020; 116:199-208Eggers F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501306 18. Gender equity and public health outcomes: The COVID-19 experience. J Bus Res 2020; 116:193- 198Leung TY, Sharma P, Adithipyangkul P, Hosie P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501305 19. Competing during a pandemic? Retailers' ups and downs during the COVID-19 outbreak. J Bus Res 2020; 116:209-213Pantano E, Pizzi G, Scarpi D, Dennis C. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501307 20. Marketing innovations during a global crisis: A study of China firms' response to COVID-19. J Bus Res 2020; 116:214-220Wang Y, Hong A, Li X, Gao J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501308 21. A Pandemic Forces United States to Leap Forward. J. Diabetes Sci. Technol. 2020:1932296820929412Argento NB. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486843 22. Risk Perception of COVID-19 Among the Portuguese Healthcare Professionals and General Population. J Hosp Infect 2020; Peres D, Monteiro J, Almeida M, Ladeira R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485198 23. We Are the First to Applaud You Regarding Your Efforts in COVID-19: A Message from the African Diaspora to Our Brothers and Sisters of Africa. J Racial Ethn Health Disparities 2020; Laurencin CT, McClinton A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500388 24. COVID-19 and picotechnology: Potential opportunities. Med. Hypotheses 2020; 144:109917Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32505072 25. Is Covid-19 sowing the seeds for future litigation? Med. Leg. J. 2020:25817220926943Riley-Smith Qc T, Heppinstall A, Foster F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490743 26. Ethical Framework for Nutrition Support Resource Allocation During Shortages: Lessons From COVID-19. Nutr. Clin. Pract. 2020; Barrocas A, Schwartz DB, Hasse JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492759 27. Effects of COVID-19 Home Confinement on Eating Behaviour and Physical Activity: Results of the ECLB-COVID19 International Online Survey. Nutrients 2020; 12Ammar A, Brach M, Trabelsi K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32481594 28. Dietary Choices and Habits during COVID-19 Lockdown: Experience from Poland. Nutrients 2020; 12Sidor A, Rzymski P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503173 29. Food Insecurity and COVID-19: Disparities in Early Effects for US Adults. Nutrients 2020; 12Wolfson JA, Leung CW. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498323 30. Impact of COVID-19 outbreak measures of lockdown on the Italian Carbon Footprint. Sci Total Environ 2020; 737:139806Rugani B, Caro D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492608 31. Increased ozone levels during the COVID-19 lockdown: Analysis for the city of Rio de Janeiro, Brazil. Sci Total Environ 2020; 737:139765Siciliano B, Dantas G, da Silva CM, Arbilla G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480061 32. Dwindling blood reserves: An ominous downside of COVID-19 pandemic. Transfus. Apher. Sci. 2020:102818Kumar S, Azim D, Nasim S, Hashmi SH. http://www.ncbi.nlm.nih.gov/pubmed/? term=32487511 33. How can physicians advise faith communities during the COVID-19 pandemic? Travel Med Infect Dis 2020:101762Merry SP, Havyer RD, McCoy RG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497766 34. [Thoughts and suggestions on arrangement, analysis and summary of medical data during COVID- 19 epidemic]. Zhongguo Zhong Yao Za Zhi 2020; 45:1526-1530Yan YM, Li B, Li ZY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489030

Pathology (9 articles)

1. Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2. Curr. Protoc. Microbiol. 2020; 57:ecpmc105Mendoza EJ, Manguiat K, Wood H, Drebot M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475066 2. The craniotomy box: an innovative method of containing hazardous aerosols generated during skull saw use in autopsy on a COVID-19 body. Forensic Sci. Med. Pathol. 2020; Hasmi AH, Khoo LS, Koo ZP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500339 3. Guide to forensic pathology practice for death cases related to coronavirus disease 2019 (COVID- 19) (Trial draft). Forensic Sci Res 2020; 5:1-7Mao D, Zhou N, Zheng D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490304 4. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int. J. Legal Med. 2020; Edler C, Schroder AS, Aepfelbacher M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500199 5. Gross and histopathological pulmonary findings in a COVID-19 associated death during self- isolation. Int. J. Legal Med. 2020; Suess C, Hausmann R. http://www.ncbi.nlm.nih.gov/pubmed/? term=32504146 6. Dermatopathology Education During the COVID-19 Pandemic: Virtual Simulation of the Multi- Headed Microscope. J Am Acad Dermatol 2020; Kim RH, Brinster NK, Meehan SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497706 7. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like". J Eur Acad Dermatol Venereol 2020; Mahe A, Birckel E, Merklen C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500642 8. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients. J Eur Acad Dermatol Venereol 2020; Reymundo A, Fernaldez-Bernaldez A, Reolid A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495368 9. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis 2020:101755Dhama K, Patel SK, Pathak M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479816

Protection (46 articles)

1. Securing Posterior Auricular Incision with Button Headbands in Prominent Ear Patients Wearing Surgical Masks for Self-protection in the Pandemic. Aesthetic Plast. Surg. 2020; Ozkan B, Uysal CA, Ertas NM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500322 2. Primary healthcare practitioners and patient blood management in Africa in the time of coronavirus disease 2019: Safeguarding the blood supply. Afr J Prim Health Care Fam Med 2020; 12:e1-e3Barrett CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501018 3. Respiratory protection for health care workers: A 2020 COVID-19 perspective. Am. J. Ind. Med. 2020; Petsonk EL, Harber P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496602 4. Environmental contamination of SARS-CoV-2 during the COVID-19 outbreak in South Korea. Am. J. Infect. Control 2020; Ryu BH, Cho Y, Cho OH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485273 5. Gastrointestinal endoscopy operation--A potential transmission risk for SARS-CoV-2. Am. J. Infect. Control 2020; Tan C, Xiao Y, Wu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485277 6. Decontamination of Surgical Face Masks and N95 Respirators by Dry Heat Pasteurization for One Hour at 70 degrees C. Am. J. Infect. Control 2020; Xiang Y, Song Q, Gu W. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479844 7. "Hot Zones" for Otolaryngologists: Assessing the geographic distribution of aerosol-generating procedures amidst the COVID-19 pandemic. Am. J. Otolaryngol. 2020; 41:102550Quereshy HA, Jella TK, Ruthberg JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485299 8. Notice of Retraction: Effectiveness of Surgical and Cotton Masks in Blocking SARS-CoV-2. Ann Intern Med 2020; Bae S, Kim MC, Kim JY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479106 9. Protecting staff and patients during airway management in the COVID-19 pandemic: are intubation boxes safe? Br J Anaesth 2020; Gould CL, Alexander PDG, Allen CN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473727 10. COVID-19: Transmission, Prevention, and Potential Therapeutic Opportunities. Clin Chim Acta 2020; Lotfi M, Hamblin MR, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474009 11. Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens. Curr Protoc Cytom 2020; 93:e77Bain W, Lee JS, Watson AM, Stitt-Fischer MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502333 12. Protection comes at a cost: Doctor's life inside Personal Protection Equipment. Dermatol Ther 2020:e13758Bhargava S, Gupta M, Kroumpouzos G. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495994 13. Laser Safety Measures for The Treatment of Genital Warts in Hiv+ Patients During The Covid-19 Pandemic. Dermatol Ther 2020:e13750Cameli N, Mariano M, Latini A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495468 14. Topical rh-aFGF: An effective therapeutic agent for facemask wearing-induced pressure sores. Dermatol Ther 2020:e13745Luo P, Liu D, Li J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478959 15. Safeguarding Dermatologist Attendings and Residents Amid the COVID-19 Pandemic: Focus on Special Populations. Dermatol Ther 2020:e13749Stewart CR, Lipner SR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495403 16. Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus. Emerg Infect Dis 2020; 26Fischer RJ, Morris DH, van Doremalen N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32491983 17. SARS-CoV-2 RNA Detection on Disposable Wooden Chopsticks, Hong Kong. Emerg Infect Dis 2020; 26Lui G, Lai CKC, Chen Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32491982 18. Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020. Emerg Infect Dis 2020; 26Ryu S, Ali ST, Jang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487283 19. How and why use the EasyBreath(R) Decathlon surface snorkeling mask as a personal protective equipment during the COVID-19 pandemic? Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2020; Thierry B, Celerier C, Simon F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493648 20. Endoscopic nasopharyngoscopy and ENT specialist safety in the COVID 19 era: the back endoscopy approach to the patient. Eur Arch Otorhinolaryngol 2020; Di Maio P, Traverso D, Iocca O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500327 21. The craniotomy box: an innovative method of containing hazardous aerosols generated during skull saw use in autopsy on a COVID-19 body. Forensic Sci. Med. Pathol. 2020; Hasmi AH, Khoo LS, Koo ZP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500339 22. Acidified Sodium Chlorite Solution: A Potential Prophylaxis to Mitigate Impact of Multiple Exposures to COVID-19 in Frontline Healthcare Providers. Hosp Pract (1995) 2020; Karnik-Henry MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497459 23. Facemasks for prevention of viral respiratory infections in community settings: A systematic review and meta-analysis. Indian J. Public Health 2020; 64:S192-s200Aggarwal N, Dwarakanathan V, Gautam N, Ray A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496254 24. Rational use of face mask in a tertiary care hospital setting during COVID-19 pandemic: An observational study. Indian J. Public Health 2020; 64:S225-s227Supehia S, Singh V, Sharma T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496260 25. HUMAN CORONAVIRUS DATA FROM FOUR CLINICAL TRIALS OF MASKS AND RESPIRATORS. Int J Infect Dis 2020; MacIntyre CR, Chughtai AA, Seale H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497810 26. A Potential Hidden Reservoir: The Role of Nail Hygiene in Preventing Transmission of COVID-19. J Am Acad Dermatol 2020; Wu AG, Lipner SR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497691 27. ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology. J. Am. Soc. Echocardiogr. 2020; 33:648-653Kirkpatrick JN, Mitchell C, Taub C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503700 28. Specific Considerations for Sonographers When Performing Echocardiography during the 2019 Novel Coronavirus Outbreak: Supplement to the American Society of Echocardiography Statement. J. Am. Soc. Echocardiogr. 2020; 33:654-657Mitchell C, Collins K, Hua L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503701 29. Specific Considerations for the Protection of Patients and Echocardiography Service Providers When Performing Perioperative or Periprocedural Transesophageal Echocardiography during the 2019 Novel Coronavirus Outbreak: Council on Perioperative Echocardiography Supplement to the Statement of the American Society of Echocardiography Endorsed by the Society of Cardiovascular Anesthesiologists. J. Am. Soc. Echocardiogr. 2020; 33:666-669Nicoara A, Maldonado Y, Kort S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503703 30. A modified barrier enclosure to prevent viral aerosol transmission during endotracheal intubation and extubation of patients with coronavirus disease. J. Clin. Anesth. 2020; 65:109876Kojima Y, Aoyama K, Yamagata K, Sugimura M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502759 31. Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic. J Eur Acad Dermatol Venereol 2020; Bothra A, Das S, Singh M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32491204 32. Hand Eczema Pandemic Caused by SARS-CoV-2 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital Personnel. J Eur Acad Dermatol Venereol 2020; Greveling K, Kunkeler ACM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488925 33. High SARS-CoV-2 Antibody Prevalence among Healthcare Workers Exposed to COVID-19 Patients. J Infect 2020; Chen Y, Tong X, Wang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504745 34. Temperature-dependent surface stability of SARS-CoV-2. J Infect 2020; Kratzel A, Steiner S, Todt D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504748 35. SARS, MERS and COVID-19 among healthcare workers: A narrative review. J Infect Public Health 2020; Xiao J, Fang M, Chen Q, He B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493671 36. Guidance for otolaryngology health care workers performing aerosol generating medical procedures during the COVID-19 pandemic. J. Otolaryngol. Head Neck Surg. 2020; 49:36Lammers MJW, Lea J, Westerberg BD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493489 37. COVID-19 and veterinarians for one health, zoonotic- and reverse-zoonotic transmissions. J. Vet. Sci. 2020; 21:e51Yoo HS, Yoo D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476324 38. Airborne Spread of SARS-CoV-2 and a Potential Role for Air Disinfection. JAMA 2020; Nardell EA, Nathavitharana RR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478797 39. Hydrogen peroxide and viral infections: A literature review with research hypothesis definition in relation to the current covid-19 pandemic. Med. Hypotheses 2020; 144:109910Caruso AA, Del Prete A, Lazzarino AI. http://www.ncbi.nlm.nih.gov/pubmed/?term=32505069 40. Dead body management amidst global pandemic of Covid-19. Med. Leg. J. 2020:25817220926930Vidua RK, Duskova I, Bhargava DC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501134 41. Oral saliva and COVID-19. Oral Oncol 2020; 108:104821Baghizadeh Fini M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474389 42. Rhinologic Practice Special Considerations During COVID-19: Visit Planning, Personal Protective Equipment, Testing, and Environmental Controls. Otolaryngol Head Neck Surg 2020:194599820933169Howard BE, Lal D. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484728 43. SARS-CoV-2 Infection in Health Care Workers: Cross-sectional Analysis of an Otolaryngology Unit. Otolaryngol Head Neck Surg 2020:194599820932162Paderno A, Fior M, Berretti G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482123 44. A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial. Trials 2020; 21:469Vandormael A, Adam M, Greuel M, Barnighausen T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493460 45. [Surgery during the SARS-CoV-2 pandemic : Recommendations on operative procedures]. Unfallchirurg 2020; Mahlke L, Flohe S, Matthes G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32488319 46. Surgical precautions for Urologists in the era of COVID-19. Urology 2020; Chan MC, Kwok JL, Yeo SEK, Chong YL. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504680

Pulmonary disease (10 articles)

1. Respiratory Mechanics of COVID-19 vs. Non-COVID-19 Associated Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2020; Haudebourg AF, Perier F, Tuffet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479162 2. A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2. Cureus 2020; 12:e7943Baek WK, Sohn SY, Mahgoub A, Hage R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499983 3. Refractory Acute Respiratory Distress Syndrome Secondary to COVID-19 Successfully Extubated to Average Volume-assured Pressure Support Non-invasive Ventilator. Cureus 2020; 12:e7849Mittal A, Forte M, Leonard R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483500 4. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. J Am Coll Radiol 2020; Mazzone PJ, Gould MK, Arenberg DA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485147 5. Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea. J Clin Med 2020; 9Jung HY, Lim JH, Kang SH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498262 6. Inpatient Management of COVID-19 Pneumonia: a Practical Approach from the Hospitalist Perspective. J Gen Intern Med 2020; Cutler TS, Eisenberg N, Evans AT. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500328 7. COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma. J Investig Med High Impact Case Rep 2020; 8:2324709620933438Kichloo A, Aljadah M, Albosta M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500773 8. Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges. Respir Med Res 2020; 78:100764Deslee G, Zysman M, Burgel PR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32498023 9. Radiology of COVID-19 Pneumonia - Pictorial Essay and Structured Reporting. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2020; 192:513-517Schaible J, Meiler S, Poschenrieder F et al. 10. [Application of Reyanning Mixture in evaluating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome]. Zhongguo Zhong Yao Za Zhi 2020; 45:1465-1472Bao L, Shi YJ, Geng ZH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489022

Renal disease (8 articles)

1. Kidney Infarction in Patients With COVID-19. Am J Kidney Dis 2020; Post A, den Deurwaarder ESG, Bakker SJL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479921 2. Disaster Response to the COVID-19 Pandemic for Patients with Kidney Disease in New York City. J Am Soc Nephrol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499395 3. Hemodialysis with Cohort Isolation to Prevent Secondary Transmission during a COVID-19 Outbreak in Korea. J Am Soc Nephrol 2020; Cho JH, Kang SH, Park HC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482688 4. Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury. J Clin Med 2020; 9Lim JH, Park SH, Jeon Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503180 5. COVID-19 and Renal Failure: Challenges in the Delivery of Renal Replacement Therapy. J. Clin. Med. Res. 2020; 12:276-285Adapa S, Aeddula NR, Konala VM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489502 6. COVID-19 and kidney transplantation: an Italian Survey and Consensus. J Nephrol 2020; Vistoli F, Furian L, Maggiore U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495231 7. Review of the present features and the infection control challenges of COVID-19 pandemic in dialysis facilities. Kaohsiung J. Med. Sci. 2020; Lee JJ, Hwang SJ, Huang JF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492290 8. Renal Monomorphology in COVID-19 with Acute Renal Insufficiency. Praxis 2020:1-5Tuma J, Neugebauer F, Rohacek M, Serra A.

Reviews (33 articles)

1. Coronavirus Disease 2019: Clinical Review. Acta Med Port 2020; Gouveia CC, Campos L. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498762 2. Dysfunctional Coagulation in COVID-19: From Cell to Bedside. Adv Ther 2020; Wang J, Saguner AM, An J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504450 3. Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2? Am J Physiol Endocrinol Metab 2020; Cao X, Yin R, Albrecht H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501731 4. Understanding the age divide in COVID-19: Why are children overwhelmingly spared? Am J Physiol Lung Cell Mol Physiol 2020; Lingappan K, Karmouty-Quintana H, Davies J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32491949 5. A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2. Cureus 2020; 12:e7943Baek WK, Sohn SY, Mahgoub A, Hage R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499983 6. Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials. Cureus 2020; 12:e8342Bhagavathula AS, Aldhaleei WA, Rovetta A, Rahmani J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494546 7. COVID-19 Pandemic: A Neurological Perspective. Cureus 2020; 12:e7889Lahiri D, Ardila A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489743 8. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details. Eur. J. Neurol. 2020; Romoli M, Jelcic I, Bernard-Valnet R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503088 9. COVID-19 breakthroughs: separating fact from fiction. Febs j 2020; Dhillon P, Breuer M, Hirst N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500928 10. Beyond COVID-19: How the 'dismal science' can prepare us for the future. Health Econ. 2020; Chilton S, Nielsen JS, Wildman J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488905 11. Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): A systematic review. Integr Med Res 2020; 9:100426Yang M, Shang YX, Tian ZY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32483523 12. Rapid Systematic Review: The Impact of Social Isolation and Loneliness on the Mental Health of Children and Adolescents in the Context of COVID-19. J. Am. Acad. Child Adolesc. Psychiatry 2020; Loades ME, Chatburn E, Higson-Sweeney N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504808 13. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management. J. Diabetes Sci. Technol. 2020:1932296820930025Ceriello A, Schnell O. http://www.ncbi.nlm.nih.gov/pubmed/? term=32475168 14. SARS, MERS and COVID-19 among healthcare workers: A narrative review. J Infect Public Health 2020; Xiao J, Fang M, Chen Q, He B. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493671 15. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol 2020; Lotfi M, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492197 16. COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature. J Med Virol 2020; Murt A, Eskazan AE, Yilmaz U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497344 17. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature. J Med Virol 2020; Ozaras R, Cirpin R, Duran A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497283 18. Novel therapeutic approaches for treatment of COVID-19. J. Mol. Med. (Berl.) 2020; Hossein- Khannazer N, Shokoohian B, Shpichka A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494931 19. What orthopedic surgeons need to know about Covid-19 pandemic. J Orthop 2020; 21:275-277Emara K, Emara AK, Farhan M, Mahmoud S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501382 20. COVID-19 update: Covid-19-associated coagulopathy. J. Thromb. Thrombolysis 2020; Becker RC. http://www.ncbi.nlm.nih.gov/pubmed/?term=32415579 21. The immune system and COVID-19: Friend or foe? Life Sci 2020:117900Yazdanpanah F, Hamblin MR, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32502542 22. What would Sergio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system? Med. Hypotheses 2020; 143:109886Nicolau LAD, Magalhaes PJC, Vale ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504925 23. An update of treatments against COVID-19. SARS-CoV-2 pandemic. MMW-Fortschritte der Medizin 2020; 162:20-23Müller T. 24. COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 2020; Teuwen LA, Geldhof V, Pasut A, Carmeliet P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32439870 25. The neurological manifestations of COVID-19: a review article. Neurol Sci 2020; Niazkar HR, Zibaee B, Nasimi A, Bahri N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483687 26. A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions. Pathogens 2020; 9Neerukonda SN, Katneni U. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485970 27. Clinical Manifestations of Children with COVID-19: a Systematic Review. Pediatr Pulmonol 2020; de Souza TH, Nadal JA, Nogueira RJN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492251 28. SARS-CoV-2 and COVID-19: between pathophysiology complexity and therapeutic uncertainty. Physiol Rev 2020; Romagnoli S, Peris A, de Gaudio AR, Geppetti P. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496872 29. A systematic review of chest imaging findings in COVID-19. Quant Imaging Med Surg 2020; 10:1058- 1079Sun Z, Zhang N, Li Y, Xu X. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489929 30. Paediatric aspects of COVID-19: An update. Respir Med Res 2020; 78:100765Kammoun R, Masmoudi K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504982 31. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res 2020; 192:152- 160Al-Ani F, Chehade S, Lazo-Langner A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485418 32. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis 2020:101755Dhama K, Patel SK, Pathak M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479816 33. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J. Gastroenterol. 2020; 26:2323-2332Cha MH, Regueiro M, Sandhu DS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476796

Risk factors (41 articles)

1. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY) 2020; 12Asselta R, Paraboschi EM, Mantovani A, Duga S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501810 2. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages. Aging (Albany NY) 2020; 12Zhao M, Wang M, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499448 3. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis. Aging Dis 2020; 11:668-678Liu H, Chen S, Liu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489711 4. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020; Radzikowska U, Ding M, Tan G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496587 5. Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2? Am J Physiol Endocrinol Metab 2020; Cao X, Yin R, Albrecht H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501731 6. Reply to Jakovac; Severity of COVID-19 infection in patients with phenylketonuria: is vitamin D status protective? Am J Physiol Endocrinol Metab 2020; 318:E890-e891Rocha JC, Calhau C, MacDonald A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479158 7. Understanding the age divide in COVID-19: Why are children overwhelmingly spared? Am J Physiol Lung Cell Mol Physiol 2020; Lingappan K, Karmouty-Quintana H, Davies J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32491949 8. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann. Hematol. 2020; Liu X, Zhang R, He G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495027 9. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Biomark. Med. 2020; Li J, Li M, Zheng S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490680 10. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections. Biomed. Pharmacother. 2020; 128:110296Ghafouri-Fard S, Noroozi R, Vafaee R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480226 11. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell 2020; Shen B, Yi X, Sun Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492406 12. Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? Clin Rheumatol 2020; Vakil-Gilani K, O'Rourke K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474884 13. Biomarkers associated with COVID-19 disease progression. Crit. Rev. Clin. Lab. Sci. 2020:1-11Ponti G, Maccaferri M, Ruini C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503382 14. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection. Diabetes Obes. Metab. 2020; Wu J, Zhang J, Sun X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496012 15. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 2020; 9:1123-1130Han H, Ma Q, Li C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475230 16. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression. Emerg Microbes Infect 2020; 9:1096-1101Shen L, Wang C, Zhao J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476607 17. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J 2020; Gao C, Cai Y, Zhang K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498076 18. Active smoking and severity of coronavirus disease 2019 (COVID-19): Differences in measurement of variables could cause errors in the results. Eur J Intern Med 2020; Jj S, N A, E G. http://www.ncbi.nlm.nih.gov/pubmed/?term=32499172 19. Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications. In Vivo 2020; 34:1589-1592Smetana K, Jr., Brabek J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503815 20. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J. Clin. Endocrinol. Metab. 2020; Bello-Chavolla OY, Bahena-Lopez JP, Antonio-Villa NE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474598 21. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay. J. Clin. Lab. Anal. 2020:e23391Gu X, Li X, An X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32488888 22. Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients. J Clin Med 2020; 9Cheng FY, Joshi H, Tandon P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492874 23. Estimating the Risk of COVID-19 Death During the Course of the Outbreak in Korea, February-May 2020. J Clin Med 2020; 9Shim E, Mizumoto K, Choi W, Chowell G. http://www.ncbi.nlm.nih.gov/pubmed/? term=32485871 24. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? J. Endocrinol. Invest. 2020; Filardi T, Morano S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495299 25. Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis. J Infect 2020; Liu M, Gao Y, Shi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474047 26. The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis. J Infect 2020; Liu M, Gao Y, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502509 27. Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19. J Infect 2020; Nguyen Y, Corre F, Honsel V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474039 28. Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend. J Infect 2020; Peng HC, Hussin N, Nalliah S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474031 29. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med 2020; Imam Z, Odish F, Gill I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498135 30. ''Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?''. J Med Virol 2020; Ikitimur H, Borku Uysal B, Cengiz M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32492209 31. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan. J Med Virol 2020; Qin L, Li X, Shi J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497297 32. Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS-CoV-2) Infection. J Med Virol 2020; Zhuang MW, Cheng Y, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497323 33. Acute pulmonary embolism in COVID-19 related hypercoagulability. J. Thromb. Thrombolysis 2020; Lorenzo C, Francesca B, Francesco P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474757 34. Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease. JCI Insight 2020; Zhao Y, Qin L, Zhang P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32501293 35. Could autism spectrum disorders be a risk factor for COVID-19? Med. Hypotheses 2020; 144:109899Lima MES, Barros LCM, Aragao GF. http://www.ncbi.nlm.nih.gov/pubmed/?term=32505067 36. The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19. New Microbes New Infect 2020; 36:100697Khan FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483490 37. Predicting COVID-19 Incidence Using Anosmia and Other COVID-19 Symptomatology: Preliminary Analysis Using Google and Twitter. Otolaryngol Head Neck Surg 2020:194599820932128Panuganti BA, Jafari A, MacDonald B, DeConde AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484425 38. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study. Pharmacol. Res. 2020:104965Russo V, Di Maio M, Attena E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474087 39. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study. Theranostics 2020; 10:6372-6383Xu PP, Tian RH, Luo S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483458 40. Descriptive characteristics of hospitalized adult smokers and never-smokers with COVID-19. Tob Induc Dis 2020; 18:46Kalan ME, Ghobadi H, Taleb ZB et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489343 41. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci 2020; Goker H, Aladag Karakulak E, Demiroglu H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496734

Safety (17 articles)

1. Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19. Circulation 2020; Mazzanti A, Briani M, Kukavica D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501756 2. Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19. Clin Transl Sci 2020; Irie K, Nakagawa A, Fujita H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475019 3. Renin-Angiotensin-System (RAS) and COVID-19 - On the Prescription of RAS Blockers. Deutsche Medizinische Wochenschrift 2020; 145:682-686Kreutz R, Abd El-Hady Algharably E, Ganten D, Messerli F. 4. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J 2020; Gao C, Cai Y, Zhang K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498076 5. Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection. Eur. J. Haematol. 2020; Afra TP, Nampoothiri RV, Razmi TM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500556 6. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality. Hypertension 2020; Zhou F, Liu YM, Xie J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493070 7. COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia. Infect Dis Ther 2020; Povoa HCC, Chianca GC, Iorio N. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474891 8. Risk of using hydroxychloroquine as a treatment of COVID-19. Int. J. Risk Saf. Med. 2020; Alanagreh L, Alzoughool F, Atoum M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474476 9. Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin. J Cardiovasc Electrophysiol 2020; Maraj I, Hummel JP, Taoutel R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485061 10. Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable? J. Diabetes Sci. Technol. 2020:1932296820932155Koufakis T, Metallidis S, Zebekakis P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486846 11. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? J. Endocrinol. Invest. 2020; Filardi T, Morano S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495299 12. HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern. J Public Health (Oxf) 2020; Nagaraja BS, Ramesh KN, Dhar D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490532 13. Probiotics and COVID-19: is there any link? Lett. Appl. Microbiol. 2020; Akour A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495940 14. First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19. Liver Int 2020; Muhovic D, Bojovic J, Bulatovic A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32478465 15. Nicotinamide Riboside-The Current State of Research and Therapeutic Uses. Nutrients 2020; 12Mehmel M, Jovanovic N, Spitz U. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486488 16. Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations. Saf Sci 2020; 129:104842Karalis V, Ismailos G, Karatza E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501367 17. [Pharmacovigilance study on drug-induced cardiac injury during treatment of COVID-19]. Zhongguo Zhong Yao Za Zhi 2020; 45:2275-2286Zhang D, Lyu JT, Zhang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495580

Treatment options (100 articles)

1. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak. ACS Chem Neurosci 2020; Yin XX, Zheng XR, Peng W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485101 2. Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease. Aging Dis 2020; 11:465-469Gentile P, Sterodimas A. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489692 3. Mesenchymal Stem Cells for Coronavirus (COVID-19)-Induced Pneumonia: Revisiting the Paracrine Hypothesis with New Hopes? Aging Dis 2020; 11:477-479Ozturk S, Elcin AE, Elcin YM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489694 4. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Ann. Clin. Microbiol. Antimicrob. 2020; 19:23Sharun K, Dhama K, Patel SK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32473642 5. S1 Subunit and Host Proteases as Potential Therapeutic Avenues for the Treatment of COVID-19. Arch Med Res 2020; Arafah A, Ali S, Yatoo AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493626 6. Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19. Arch Med Res 2020; Saha A, Sharma AR, Bhattacharya M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32482373 7. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2. Arch Med Res 2020; Satarker S, Nampoothiri M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493627 8. Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like Cells. Biomedicines 2020; 8Park JB, Peters R, Pham Q, Wang TTY. http://www.ncbi.nlm.nih.gov/pubmed/? term=32485858 9. A lesson from a saboteur: high molecular weight kininogen (HMWK) impact in COVID-19. Br. J. Pharmacol. 2020; Colarusso C, Terlizzi M, Pinto A, Sorrentino R. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497257 10. The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic. Carbohydr Polym 2020; 240:116346Cao P, Wu S, Wu T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475597 11. The potential insights of Traditional Chinese Medicine on treatment of COVID-19. Chin. Med. 2020; 15:51Tong T, Wu YQ, Ni WJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32483409 12. Can an Old Ally Defeat a New Enemy? Circulation 2020; Gurbel PA, Bliden KP, Schror K. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478567 13. Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19. Circulation 2020; Mazzanti A, Briani M, Kukavica D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501756 14. Treating COVID-19 with colchicine in community healthcare setting. Clin Immunol 2020; 217:108490Della-Torre E, Della-Torre F, Kusanovic M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32492478 15. Treating COVID-19 with colchicine in community healthcare setting. Clin Immunol 2020:108490Della- Torre E, Della-Torre F, Kusanovic Pcp M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492478 16. Dose Optimization of Hydroxychloroquine for COVID-19: Do Blood Concentrations Matter? Clin Infect Dis 2020; Ippolito MM, Flexner C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474576 17. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients. Clin Infect Dis 2020; Wang X, Guo X, Xin Q et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32497196 18. Does vitamin D deficiency increase the severity of COVID-19? Clin Med (Lond) 2020; Weir EK, Thenappan T, Bhargava M, Chen Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503801 19. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? Clin Rheumatol 2020; Ibanez S, Martinez O, Valenzuela F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495226 20. Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19. Clin Transl Sci 2020; Irie K, Nakagawa A, Fujita H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475019 21. Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials. Cureus 2020; 12:e8342Bhagavathula AS, Aldhaleei WA, Rovetta A, Rahmani J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494546 22. Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission-A Preliminary Report of a Retrospective Cohort Study. Curr Med Sci 2020; Zhang JN, Wang WJ, Peng B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474860 23. Potential role of Anti-IL-17 in COVID-19 treatment. Dermatol Ther 2020:e13715Ayhan E, Ozturk M, An I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475041 24. Renin-Angiotensin-System (RAS) and COVID-19 - On the Prescription of RAS Blockers. Deutsche Medizinische Wochenschrift 2020; 145:682-686Kreutz R, Abd El-Hady Algharably E, Ganten D, Messerli F. 25. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents. Epigenomics 2020; Ayaz S, Crea F. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495654 26. Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection. Eur. J. Haematol. 2020; Afra TP, Nampoothiri RV, Razmi TM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500556 27. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med 2020; Campochiaro C, Della-Torre E, Cavalli G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482597 28. Does lopinavir measure up in the treatment of Covid-19? Expert Opin Investig Drugs 2020; Doggrell SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475183 29. Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series. Gut 2020; Janowitz T, Gablenz E, Pattinson D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32499303 30. NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19. Immunol. Invest. 2020:1-9Kerboua KE. http://www.ncbi.nlm.nih.gov/pubmed/?term=32482134 31. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2. In Vivo 2020; 34:1567-1588Andreou A, Trantza S, Filippou D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503814 32. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. In Vivo 2020; 34:1597-1602Bimonte S, Crispo A, Amore A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503817 33. Oral Methioninase for Covid-19 Methionine-restriction Therapy. In Vivo 2020; 34:1593-1596Hoffman RM, Han Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503816 34. Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications. In Vivo 2020; 34:1589-1592Smetana K, Jr., Brabek J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503815 35. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say? Indian J. Public Health 2020; 64:S125-s127Nina PB, Dash AP. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496241 36. Empirical Treatment and Prevention of COVID-19. Infect Chemother 2020; Shin HS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32476308 37. Tocilizumab administration in a refractory case of COVID-19. Int J Antimicrob Agents 2020:106043Dastan F, Nadji SA, Saffaei A, Tabarsi P. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502524 38. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research. Int J Cardiol 2020; Frigerio M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473921 39. Lack of Antiviral Activity of Darunavir against SARS-CoV-2. Int J Infect Dis 2020; De Meyer S, Bojkova D, Cinatl J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479865 40. Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations. Int J Mol Sci 2020; 21Hagar M, Ahmed HA, Aljohani G, Alhaddad OA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486229 41. Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases. Int J Mol Sci 2020; 21Wang X, Xia S, Wang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32481690 42. Risk of using hydroxychloroquine as a treatment of COVID-19. Int. J. Risk Saf. Med. 2020; Alanagreh L, Alzoughool F, Atoum M. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474476 43. Convalescent plasma therapy in the treatment of COVID-19: practical considerations: Correspondence. Int J Surg 2020; Islam A, Rafiq S, Karim S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502707 44. Antiviral Effects of Probiotic metabolites on COVID-19. J Biomol Struct Dyn 2020:1-11Anwar F, Altayb HN, Al-Abbasi FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32475223 45. Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin. J Cardiovasc Electrophysiol 2020; Maraj I, Hummel JP, Taoutel R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32485061 46. Interleukin-17: a potential therapeutic target in COVID-19. J Infect 2020; Mendoza VMM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504739 47. Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend. J Infect 2020; Peng HC, Hussin N, Nalliah S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32474031 48. Does type of immunosupression influence the course of Covid-19 infection? J Infect 2020; Razanamahery J, Soumagne T, Humbert S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504741 49. ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic. J. Med. Toxicol. 2020; Stolbach AI, Mazer-Amirshahi M, Marino R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500283 50. ''Tociluzumab challenge: A series of cytokine storm therapy experience in hospitalized Covid-19 pneumonia patients''. J Med Virol 2020; Borku Uysal B, Ikitimur H, Yavuzer S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484930 51. Feasibility of Tocilizumab in ICU patients with COVID-19. J Med Virol 2020; Issa N, Dumery M, Guisset O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32484915 52. Tocilizumab Administration in Patients with SARS-CoV-2 Infection: Subcutaneous Injection versus Intravenous Infusion. J Med Virol 2020; Shabani M, Shokouhi S, Moradi O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492210 53. COVID-19 patients benefit from early antiviral treatment: a comparative, retrospective study. J Med Virol 2020; Yu T, Tian C, Chu S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492205 54. A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19. J Med Virol 2020; Zhang Z, Wang S, Tu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501538 55. Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China. J Med Virol 2020; Zuo Y, Liu Y, Zhong Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492211 56. Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial? J Microbiol Immunol Infect 2020; Owa AB, Owa OT. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474026 57. Novel therapeutic approaches for treatment of COVID-19. J. Mol. Med. (Berl.) 2020; Hossein- Khannazer N, Shokoohian B, Shpichka A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494931 58. HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern. J Public Health (Oxf) 2020; Nagaraja BS, Ramesh KN, Dhar D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490532 59. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications. Life Sci 2020:117905Banu N, Panikar SS, Leal LR, Leal AR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504757 60. First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19. Liver Int 2020; Muhovic D, Bojovic J, Bulatovic A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32478465 61. Nebulized Lidocaine in COVID-19, An Hypothesis. Med. Hypotheses 2020; 144:109947Ali ZA, El- Mallakh RS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32505070 62. Hydrogen peroxide and viral infections: A literature review with research hypothesis definition in relation to the current covid-19 pandemic. Med. Hypotheses 2020; 144:109910Caruso AA, Del Prete A, Lazzarino AI. http://www.ncbi.nlm.nih.gov/pubmed/?term=32505069 63. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2. Med. Hypotheses 2020; 143:109862Poe FL, Corn J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32504923 64. Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid. Med. Hypotheses 2020; 143:109891Unal G, Turan B, Balcioglu YH. http://www.ncbi.nlm.nih.gov/pubmed/? term=32498007 65. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19. Metabolism 2020:154282Dalamaga M, Karampela I, Mantzoros CS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497535 66. An update of treatments against COVID-19. SARS-CoV-2 pandemic. MMW-Fortschritte der Medizin 2020; 162:20-23Müller T. 67. With IL-6 inhibitor against COVID-19: Corona pandemic. MMW-Fortschritte der Medizin 2020; 162:65Red. 68. Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses. Nanomaterials (Basel) 2020; 10Nasrollahzadeh M, Sajjadi M, Soufi GJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32486364 69. Reply: "Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020, 12(4), 988". Nutrients 2020; 12Grant WB, Baggerly CA, Lahore H. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492787 70. Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations. Pharmacogenomics 2020; Snyder EM, Johnson BD. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501190 71. Estimated Inactivation of Coronaviruses by Solar Radiation With Special Reference to COVID-19. Photochem. Photobiol. 2020; Sagripanti JL, Lytle CD. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502327 72. Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations. Saf Sci 2020; 129:104842Karalis V, Ismailos G, Karatza E. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501367 73. Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19. SLAS Discov 2020:2472555220934421Scalise M, Indiveri C. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500793 74. Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients. Theranostics 2020; 10:5932-5942Itani R, Tobaiqy M, Al Faraj A. http://www.ncbi.nlm.nih.gov/pubmed/? term=32483428 75. Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence. Therapie 2020; Roustit M, Guilhaumou R, Molimard M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32473812 76. Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis. Transfus. Apher. Sci. 2020:102821Cinar OE, Sayinalp B, Aladag Karakulak E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32487513 77. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:475Barnabas RV, Brown E, Bershteyn A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493478 78. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:491Bosteels C, Maes B, Van Damme K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503663 79. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial. Trials 2020; 21:489Dalili N, Kashefizadeh A, Nafar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503620 80. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. Trials 2020; 21:462Gorman E, Shankar-Hari M, Hopkins P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32493473 81. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial. Trials 2020; 21:473Irvani SSN, Golmohammadi M, Pourhoseingholi MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493468 82. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:488Li J, Zhang C, Wu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503657 83. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:485Lyngbakken MN, Berdal JE, Eskesen A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503662 84. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:468Maes B, Bosteels C, De Leeuw E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493441 85. Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trial. Trials 2020; 21:474Malhotra A, Ernest D, Rogers BA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493459 86. Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:467Pirjani R, Soori T, Dehpour AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493447 87. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:470Rilinger J, Kern WV, Duerschmied D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493514 88. Two Randomized Controlled Trials of Bacillus Calmette-Guerin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials. Trials 2020; 21:481Ten Doesschate T, Moorlag S, van der Vaart TW et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503602 89. Response to letter to the editor: radiological approaches to COVID-19 pneumonia. Turk J Med Sci 2020; Akcay MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490639 90. Letter to the Editor: Radiological approaches to COVID-19 pneumonia. Turk J Med Sci 2020; Ufuk F, Savas R, Hazirolan T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490640 91. [Therapeutic effect of Compound Qinlan Oral Liquid on treating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome]. Zhongguo Zhong Yao Za Zhi 2020; 45:1473-1480Bao YY, Shi YJ, Guo SS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489023 92. [Discovery of intervention effect of Chinese herbal formulas on COVID-19 pulmonary fibrosis treated by VEGFR and FGFR inhibitors]. Zhongguo Zhong Yao Za Zhi 2020; 45:1481-1487Bian YQ, Ma J, Ren Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489024 93. [Analysis of 131 cases of COVID-19 treated with Ganlu Xiaodu Decoction]. Zhongguo Zhong Yao Za Zhi 2020; 45:2232-2238Chen L, Cheng ZQ, Liu F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495575 94. [Visual analysis of coronavirus disease 2019 (COVID-19) studies based on bibliometrics]. Zhongguo Zhong Yao Za Zhi 2020; 45:2239-2248Chen Y, Guo YB, Guo R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32495576 95. [Usage of ethnomedicine on COVID-19 in China]. Zhongguo Zhong Yao Za Zhi 2020; 45:2265-2274Li ZY, Tuya, Li HT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495579 96. [Rationality of Asari Radix et Rhizoma in Qingfei Paidu Decoction based on literature analysis]. Zhongguo Zhong Yao Za Zhi 2020; 45:1515-1520Qin ZN, Wang MX, Shi NN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489028 97. [Suggestions on design of evidence-based traditional Chinese medicine clinical study for new public health emergencies]. Zhongguo Zhong Yao Za Zhi 2020; 45:2291-2295Wang LX, Xie YM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495582 98. [Recent advances in treatment of viral pneumonia using Chinese patent medicine]. Zhongguo Zhong Yao Za Zhi 2020; 45:1509-1514Wang T, Han LF, Wang YF et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32489027 99. [Treatment of COVID-19 guided by holistic view of traditional Chinese medicine--therapy aimed at both viral and host]. Zhongguo Zhong Yao Za Zhi 2020; 45:1521-1525Yuan R, Xin QQ, Tang SH, Cong WH. http://www.ncbi.nlm.nih.gov/pubmed/?term=32489029 100. [Pharmacovigilance study on drug-induced cardiac injury during treatment of COVID-19]. Zhongguo Zhong Yao Za Zhi 2020; 45:2275-2286Zhang D, Lyu JT, Zhang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32495580

Trials (19 articles) 1. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2020; Anker SD, Butler J, Khan MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498081 2. Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): A systematic review. Integr Med Res 2020; 9:100426Yang M, Shang YX, Tian ZY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32483523 3. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study. Intern Emerg Med 2020; Lapostolle F, Schneider E, Vianu I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32474850 4. Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China. J Med Virol 2020; Zuo Y, Liu Y, Zhong Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32492211 5. HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern. J Public Health (Oxf) 2020; Nagaraja BS, Ramesh KN, Dhar D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32490532 6. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:475Barnabas RV, Brown E, Bershteyn A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493478 7. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:472Cuadrado-Lavin A, Olmos JM, Cifrian JM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32493494 8. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial. Trials 2020; 21:489Dalili N, Kashefizadeh A, Nafar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503620 9. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:466Garcia IG, Rodriguez-Rubio M, Mariblanca AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493475 10. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. Trials 2020; 21:462Gorman E, Shankar-Hari M, Hopkins P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32493473 11. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial. Trials 2020; 21:473Irvani SSN, Golmohammadi M, Pourhoseingholi MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493468 12. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:488Li J, Zhang C, Wu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32503657 13. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:485Lyngbakken MN, Berdal JE, Eskesen A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503662 14. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:468Maes B, Bosteels C, De Leeuw E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493441 15. Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trial. Trials 2020; 21:474Malhotra A, Ernest D, Rogers BA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493459 16. Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:467Pirjani R, Soori T, Dehpour AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493447 17. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21:470Rilinger J, Kern WV, Duerschmied D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493514 18. Two Randomized Controlled Trials of Bacillus Calmette-Guerin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials. Trials 2020; 21:481Ten Doesschate T, Moorlag S, van der Vaart TW et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32503602 19. A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial. Trials 2020; 21:469Vandormael A, Adam M, Greuel M, Barnighausen T. http://www.ncbi.nlm.nih.gov/pubmed/?term=32493460

Vaccines (5 articles)

1. On setting expectations for a SARS-CoV-2 Vaccine. Clin Infect Dis 2020; Canaday DH, Gravenstein S. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497168 2. Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials. Cureus 2020; 12:e8342Bhagavathula AS, Aldhaleei WA, Rovetta A, Rahmani J. http://www.ncbi.nlm.nih.gov/pubmed/?term=32494546 3. Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality? Hum Vaccin Immunother 2020:1-2Anbarasu A, Ramaiah S, Livingstone P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32501133 4. COVID-19 vaccine development and the way forward. Indian J. Public Health 2020; 64:S108-s111Arora NK, Das MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=32496238 5. Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis. Med. Hypotheses 2020; 143:109849Meenakshisundaram R, Senthilkumaran S, Thirumalaikolundusubramanian P. http://www.ncbi.nlm.nih.gov/pubmed/?term=32480250

Women – pregnancy (10 articles)

1. Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study. Bjog 2020; Mendoza M, Garcia-Ruiz I, Maiz N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479682 2. Breastfeeding during the COVID-19 pandemic: suggestions on behalf of Woman Study Group of AMD. Diabetes Res Clin Pract 2020:108239Giuliani C, Li Volsi P, Brun E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32479766 3. Universal screening for SARS-CoV-2 in asymptomatic obstetric patients in Tokyo, Japan. Int J Gynaecol Obstet 2020; Ochiai D, Kasuga Y, Iida M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32496574 4. Rheumatic diseases during pregnancy and SARS-CoV-2: An appeal for medication adherence. Int J Gynaecol Obstet 2020; Scioscia M, Praino E, Scioscia C. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502303 5. Provisions for Obstetrics and Gynaecology - letter to the editor on "Impact of the coronavirus (COVID-19) pandemic on surgical practice - Part 2 (surgical prioritisation)": A correspondence. Int J Surg 2020; Sookramanien SP, Sookramanien SR, Shubber N. http://www.ncbi.nlm.nih.gov/pubmed/? term=32502706 6. Wet Nurses to Donor Milk Banks and Back Again: The Continuum of Sharing Our Milk to Save Lives. J Hum Lact 2020; 36:213-216Marinelli KA. http://www.ncbi.nlm.nih.gov/pubmed/?term=32478620 7. Relationship between pregnancy and coronavirus: what we know. J Matern Fetal Neonatal Med 2020:1-12Forestieri S, Marcialis MA, Migliore L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498581 8. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan. J Med Virol 2020; Qin L, Li X, Shi J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32497297 9. Clinical update on COVID-19 in pregnancy: A review article. J. Obstet. Gynaecol. Res. 2020; Ryean GA, Purandare NC, McAuliffe FM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32500549 10. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Espanola de Ginecologia y Obstetricia and Sociedad Espanola de Trombosis y Hemostasia. Maturitas 2020; 137:57-62Ramirez I, De la Viuda E, Baquedano L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32498938

to subscribe click here